User Image Cart Icon 4 Search Image

Appetite Suppressants

  1.  Slimming food supplements adulterated with sibutramine and phenolphthalein
  2.  Too Fat Part Two!…
  3. … , double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects
  4. (S)-3-[(Benzyloxy) methyl] morpholine hydrochloride: a nonstimulant appetite suppressant without conventional neurotransmitter releasing properties
  5. 1-(m-Chlorophenyl) piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain
  6. 10. Drugs Affecting Cholinergic Neurotransmission
  7. 101 Things to Do Before You Diet: Because Looking Great Isn’t Just about Losing Weight
  8. 19 Diabetes and Herbal
  9. 3 CNTF and Related Neurokines
  10. 360-Degree Perspectives on Obesity
  11. 365 Skinny Smoothies: Healthy, Never-Boring Recipes with 52 Weekly Shopping Lists for Stress-Free Weight Loss
  12. 5-HT2B receptor antagonists inhibit fibrosis and protect from RV heart failure
  13. 5-HTP: The natural way to overcome depression, obesity, and insomnia
  14. 5-Hydroxyindole-2-carboxylic acid amides: novel histamine-3 receptor inverse agonists for the treatment of obesity
  15. 50 Ways to Boost Your Metabolism: How Mustard, Red Wine, and Days at the Beach Can Help You Lose Weight & Stay Healthy
  16. 7 Acetylcholinesterase inhibitory activity of spices and culinary herbs
  17. 7 Weight Management
  18. 9 Best Thermogenic Fat Burners in 2022 for Weight Loss
  19. A behavioral approach to weight management
  20. A Behavioural Genetic Model of the Mechanisms Underlying the Link Between Obesity and Dimensional Measures of Attention-Deficit/Hyperactivity Disorder (ADHD)
  21. A bidirectional network for appetite control in larval zebrafish
  22. A bidirectional network for appetite control in larval zebrafish
  23. A bidirectional network for appetite control in zebrafish
  24. A botanical approach to managing obesity
  25. A cholinergic basal forebrain feeding circuit modulates appetite suppression
  26. A combined healthy strategy for successful weight loss, weight maintenance and improvement of hepatic lipid metabolism
  27. A Comparison Study between Orlistat and Moringa Oleifera as an Appetite Suppressant in Case of Obese Patients
  28. A content analysis of marketing on the packages of dietary supplements for weight loss and muscle building
  29. A contextual analysis of obesity and smoking among women in Oklahoma City
  30. A Cost-Effective Analysis of Appetite Suppressants for Obesity Treatment in a Managed Care Organization
  31. A critical review on obesity: Herbal approach, bioactive compounds, and their mechanism
  32. A dual role for astroglia in substituted amphetamine-induced serotonin nerve degeneration: Neuroprotective and neurotoxic
  33. A flavonoid-rich fraction of Monolluma quadrangula inhibits xanthine oxidase and ameliorates potassium oxonate-induced hyperuricemia in rats
  34. A Functional Magnetic Resonance Imaging Study Evaluating the Effects of Intranasal Insulin on Food Related Reward and Appetite
  35. A GC–EI-MS-MS method for simultaneous determination of seven adulterants in slimming functional foods
  36. A herbal approach to obesity Management: a review
  37. A high-throughput fluorescence-based assay system for appetite-regulating gene and drug screening
  38. A history of neuromuscular block and its antagonism
  39. A low carbohydrate diet: Treating obesity related disorders in adults
  40. A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial
  41. A Mechanistic Review of Anti-Obesity Drugs
  42. A medicinal plants survey for treatment of obesity
  43. A Multi-Ingredient Supplement Protects against Obesity and Infertility in Western Diet-Fed Mice
  44. A multimodal approach to the treatment of obesity
  45. A natural solution for obesity: Bioactives for the prevention and treatment of weight gain. A review
  46. A new TLC bioautographic assay for qualitative and quantitative estimation of lipase inhibitors
  47. A new use for old drugs: identifying compounds with an anti-obesity effect using a high through-put semi-automated Caenorhabditis elegans screening platform
  48. A novel aminosterol reverses diabetes and fatty liver disease in obese mice
  49. A pilot study investigating the effect of Caralluma fimbriata extract on the risk factors of metabolic syndrome in overweight and obese subjects: a randomised controlled …
  50. A pilot study of medication and group therapy for obesity in a group of physicians.
  51. A placebo-controlled randomized trial of the effects of PPA and nicotine gum on cessation rates and post-cessation weight gain in women
  52. A Potential Phytomedicine for Obesity from the Leaves of Dalbergia Sissoo Roxb using Zebrafish (Danio Rerio)-A Metabolomic Approach for Future Herbal Drug …
  53. A problem-solving approach to the treatment of obesity
  54. A Qualitative Study of the Lived Experiences of Obese African American Women
  55. A resurging boom in new drugs for epilepsy and brain disorders
  56. A Retrospective Comparative Analysis on the Effectiveness of Pharmacologic Weight Loss
  57. A review of monoaminergic neuropsychopharmacology in zebrafish, 6 years later: towards paradoxes and their solution
  58. A review of potential marine-derived hypotensive and anti-obesity peptides
  59. A review on “Garcinia cambogia-a weight controlling agent”
  60. A review on botanical species and chemical compounds with appetite suppressing properties for body weight control
  61. A review on obesity and its management
  62. A review on possible therapeutic targets to contain obesity: The role of phytochemicals
  63. A review on prescription and non-prescription appetite suppressants and evidence-based method to treat overweight and obesity
  64. A review on the current drugs and new targets for obesity
  65. A review on the potential use of natural products in overweight and obesity
  66. A review on the role of food-derived bioactive molecules and the microbiota–gut–brain axis in satiety regulation
  67. A role for the inhibition of monoamine oxidase A in the neurotoxic mechanism of substituted amphetamines
  68. A simple and fast-portable method for the screening of the appetite-suppressant drug sibutramine in natural products and multivitamins supplements
  69. A spermine-coupled cholesterol metabolite from the shark with potent appetite suppressant and antidiabetic properties
  70. A step towards developing the expertise to control hunger and satiety: Regulatory role of satiomem—A membrane proteoglycan
  71. A student’s dictionary of psychology and neuroscience
  72. A Study of Obesity in General Practice
  73. A Study on Factors on Postpartum Obesity and Postpartum Depression in Korea.
  74. A systematic review and meta-analysis of randomised controlled trials of treatments for clozapine-induced obesity and metabolic syndrome
  75. A systematic review of dietary supplements and alternative therapies for weight loss
  76. A systematic review of the European rapid alert system for food and feed: tendencies in illegal food supplements for weight loss
  77. A systematic review of the potential effects of thylakoids in the management of obesity and its related issues
  78. Abdominal obesity, liver fat and muscle composition in young adult survivors of childhood acute lymphoblastic leukemia.
  79. ABERRANT METABOLIC AND SIGNALING PATHWAYS UNDERLIE IMPAIRED STEM CELL FUNCTION IN HUMAN OBESITY
  80. About body wraps, pills and other magic wands for losing weight
  81. Activation of tyrosine phosphatase PTP1B in pyramidal neurons impairs endocannabinoid signaling by tyrosine receptor kinase trkB and causes schizophrenia-like …
  82. Acute and chronic administration of melanin-concentrating hormone enhances food intake and body weight in Wistar and Sprague–Dawley rats
  83. Acute effects of exercise on appetite, food intake and circulating concentrations of gastrointestinal hormones
  84. Acute feeding suppression and toxicity of raspberry ketone [4-(4-hydroxyphenyl)-2-butanone] in mice
  85. Acute Inflammatory Response as a Mediator of the Effects of High-intensity Exercise on Appetite and Food Intake in Boys
  86. Acute pancreatitis secondary to use of appetite suppressant: Garcinia cambogia
  87. Acute physical exercise increases PI3K‐p110α protein content in the hypothalamus of obese mice
  88. Addiction-like response in brain and behavior in a rat experimental model of night-eating syndrome
  89. Adipose and non-adipose perspectives of plant derived natural compounds for mitigation of obesity
  90. Adipose aromatase gene expression is greater in older women and is unaffected by postmenopausal estrogen therapy
  91. Adipose tissue as a possible therapeutic target for polyphenols: A case for Cyclopia extracts as anti-obesity nutraceuticals
  92. Adipose tissue engineering using injectable, oxidized alginate hydrogels
  93. Adipose tissue: friend or foe?
  94. Adiposity in childhood brain tumors: prevalence, predictors, and current management strategies
  95. Advances in antiobesity mechanisms of capsaicin
  96. Advances in the discovery of fatty acid amide hydrolase inhibitors: what does the future hold?
  97. Advice on low‐fat diets for obesity
  98. Aetiology of Individual Obesities
  99. Affect theory and the neurobiology of affective dysregulation
  100. aging and Alzheimer’s disease through the biological mechanisms behind obesity and type II diabetes. May 2013 Health IN PRESS
  101. Aguamiel concentrate from Agave salmiana and its extracted saponins attenuated obesity and hepatic steatosis and increased Akkermansia muciniphila in …
  102. Alanine-specific appetite in slow growing chickens is associated with impaired glucose transport and TCA cycle
  103. Alcohol and cocaine abuse effects on the male reproductive neuroendocrine axis
  104. Allicin bioavailability from alliinase-inhibited garlic
  105. Allicin-rich garlic extract alleviates high-fat diet-induced complications in rats: A nutrigenomic study
  106. ALPHA (1)-ADRENERGIC RECEPTORS IN RAT BRAIN (CYCLIC-AMP)
  107. Altered metabolic gene expression in the brain of a triprolyl-human amylin transgenic mouse model of type 2 diabetes
  108. Alternative therapies: Part I. Depression, diabetes, obesity
  109. Alternative treatments for weight loss: a critical review
  110. Alternative treatments for weight loss: Safety/risks and effectiveness of anti-obesity medicinal plants
  111. Amelioration of cancer-induced cachexia by inhibition of NF-κB signaling pathway
  112. Amelioration of experimental metabolic syndrome induced in rats by orlistat and Corchorus olitorius leaf extract; role of adipo/cytokines
  113. AMELIORATIVE EFFECTS OF CLERODENDRUM PHILOMIDIS LINN. AGAINST OXIDATIVE STRESS INDUCED METABOLIC SYNDROME IN OBESE RATS.
  114. Amphetamine derivatives and obesity
  115. Amphetamine-evoked changes of oxidative stress and neuropeptide Y gene expression in hypothalamus: Regulation by the protein kinase C-δ signaling
  116. Amphetamine, an appetite suppressant, decreases neuropeptide Y immunoreactivity in rat hypothalamic paraventriculum
  117. AMPK: A POTENT TARGET FOR TREATING OBESITY.
  118. Amylin Inhibits the Feeding of the Siberian Sturgeon
  119. An appetite suppressant from Hoodia species
  120. An Approach to Obesity as a Cardiometabolic Disease: Potential Implications for Clinical Practice
  121. An assessment of herbal weight loss products
  122. An epigenetic predictor of death captures multi-modal measures of brain health
  123. An historical review of steps and missteps in the discovery of anti-obesity drugs
  124. An investigation of CYP2B in rat brain: regulation and role in drug and toxin response
  125. An Investigation of Motivational Dysfunctions in a Rat Model of Effort-Related Choice Behavior: Behavioral and Neurochemical Evidence for Possible Novel …
  126. An investigation of plant derived compounds as inhibitors of monoamine oxidase
  127. An overview of Obesityand its prevention
  128. An overview of the efficacy and safety of fenfluramine and mazindol in the treatment of obesity.
  129. An survey on obesity stigma and its assessment with update: a review
  130. Analysis of differentially expressed serum proteins during development of obesity
  131. Anesthetic ketamine impairs rats’ retrograde memory. Reversal of its behavioural effects by the nitric oxide syn-thase inhibitor L-NAME
  132. Angiogenesis in obesity
  133. Angiogenesis modulates obesity and insulin sensitivity
  134. Angiopoietin-Like Growth Factor Controls Appetite Via Leptin Signaling in the Hypothalamus
  135. Anorexia and weight loss in male rats 24 h following single dose treatment with orexin-1 receptor antagonist SB-334867
  136. Anti Obesity preparations of plant origin-are they effective? Weight reduction with Zerofat-A, in obese diabetics and non diabetics, a cross-sectional, observational pilot …
  137. Anti Obesogenic Potential of Caralluma acutangula Bioactive Fractions
  138. ANTI-DIABETES MECHANISM OF ACTION BY SYNACINN™ IN ADIPOCYTES
  139. Anti-diabetic treatment and cancer occurrence among patients with type II diabetes mellitus
  140. Anti-inflammatory nutrition as a pharmacological approach to treat obesity
  141. Anti-obese therapeutics from medicinal plants–a review
  142. Anti-obesity agents: a focused review on the structural classification of therapeutic entities
  143. Anti-obesity and anti-diabetic properties of two natural extracts rich in flavonoids (helichrysum and grapefruit): physiological and molecular mechanisms
  144. Anti-obesity and haematological effects of Malaysia Hibiscus sabdariffa L. aqueous extract on obese Sprague Dawley rats
  145. Anti-Obesity Attributes; UHPLC-QTOF-MS/MS-Based Metabolite Profiling and Molecular Docking Insights of Taraxacum officinale
  146. Anti-obesity drug development
  147. Anti-obesity drugs: a critical review of current therapies and future opportunities
  148. Anti-obesity effect of an isoflavone fatty acid ester on obese mice induced by high fat diet and its potential mechanism
  149. Anti-obesity effect of argel (Solenostemma argel) on obese rats fed a high fat diet
  150. ANTI-OBESITY EFFECT OF CROCIN AND ETHANOLIC EXTRACT OF SAFFRON (Crocus sativus L.) IN RATS FED WITH HIGH-FAT DIET
  151. Anti-obesity effect of Stellaria media methanolic extract in the murine model of cafeteria diet induced obesity
  152. Anti-obesity effect of traditional Chinese medicine and natural products
  153. Anti-obesity effects of dichloromethane leaf extract of Gnidia glauca in high fat diet-induced obese rats
  154. Anti-obesity Effects of Heloniopsis orientalis through Controlling Lipid Metabolism in High-fat induced Obesity Mouse
  155. Anti-obesity effects of medicinal plants from Asian countries and related molecular mechanisms: a review
  156. Anti-obesity effects of Yerba Mate (Ilex Paraguariensis): a randomized, double-blind, placebo-controlled clinical trial
  157. Anti-Obesity Efficacy of Lipoidal Matter of Vitis Vinifera Leaves in Rats
  158. Anti-Obesity Medication Use in Children and Adolescents with Prader–Willi Syndrome: Case Review and Literature Search
  159. Anti-obesity medications in cancer therapy: A comprehensive insight
  160. Anti-obesity medicinal plants
  161. Anti-obesity natural products
  162. Anti-obesity potential of the ethanolic extract of Alstonia boonei stem bark on high carbohydrate diet induced obesity in male Wistar rats
  163. Anti-obesity potentials of aqueous and methanol extracts of Vernonia amygdalina Del. Leaves in high-fat diet fed rats
  164. Anti-obesity study of Indonesian medicinal plants: an in vitro study in adipocytes
  165. Anti‐obesity potentiality of Tapra fish (Opisthopterus tardoore) oil
  166. Antidiabetic activities of Foeniculum vulgare Mill. essential oil in streptozotocin-induced diabetic rats
  167. Antidiabetic Drugs Can Reduce the Harmful Impact of Chronic Smoking on Post-Traumatic Brain Injuries
  169. Antidiabetic, chemical, and physical properties of organic vanadates as presumed transition-state inhibitors for phosphatases
  170. Antiobesity action of a daidzein derivative on male obese mice induced by a high-fat diet
  171. Antiobesity Drugs: Should They Be Used in the Treatment of Obesity?
  172. Antiobesity effect of Phytolacca berry in rats
  173. Antiobesity effect of Stellaria media against drug induced obesity in Swiss albino mice
  174. Antiobesity functional leads and targets for drug development
  175. Antiobesity pharmacotherapy: new drugs and emerging targets
  176. Antiobesity potential of Aconitum Heterophyllum roots
  177. Antiobesity potential of Clerodendrum phlomidis Linn. and Garcinia cambogia Linn, A comparative animal model study
  178. Antiobesogenic and Antiatherosclerotic Properties of Caralluma fimbriata Extract
  179. Appetite and Gut Hormones Response to a Putative α-Glucosidase Inhibitor, Salacia Chinensis, in Overweight/Obese Adults: A Double Blind Randomized Controlled …
  180. Appetite and the regulation of body composition
  181. Appetite control and gastrointestinal hormonal behavior (CCK, GLP-1, PYY 1–36) following low doses of a whey protein-rich nutraceutic
  182. Appetite control and obesity
  183. Appetite control: hormones or diet strategies?
  184. Appetite perceptions, gastrointestinal symptoms, ghrelin, peptide YY and state anxiety are disturbed in adolescent females with anorexia nervosa and only partially …
  185. Appetite reducing herbal drugs from the perspective of Avicenna and Aghili in Iranian traditional medicine (Persian medicine)
  186. Appetite regulation and its modulation by drugs
  187. Appetite regulation by gut peptides
  188. Appetite Suppressant-induced Propafenone Proarrhythmia
  189. Appetite suppressants and primary pulmonary hypertension in the United Kingdom.
  190. Appetite suppressants and valvular heart disease in a population-based sample: the HyperGEN study
  191. Appetite suppressants and valvular heart disease–a systematic review
  192. Appetite suppressants as agonist substitution therapies for stimulant dependence
  193. Appetite Suppressing Phyto Nutrients: Potential for Combating Obesity
  194. Appetite suppressing pregnane glycosides from the roots of Cynanchum auriculatum
  195. Appetite Suppression and Antiobesity Effect of a Botanical Composition Composed of Morus alba, Yerba mate, and Magnolia officinalis
  196. Appetite suppression during ketogenic diets: Do fecal short-chain fatty acids play a role?
  197. Appetite-suppressant drugs and the risk of primary pulmonary hypertension
  198. Appetite-suppressing and satiety-increasing bioactive phytochemicals: A systematic review
  199. Appetitive traits and their relationships to weight and weight management
  200. Application of Hibiscus sabdariffa extract to manage obesity
  201. Appraisal of the impact of Bariatric surgery on Health Related Quality of life and Work Productivity in Morbidly Obese Patients
  202. Approved and off-label uses of obesity medications, and potential new pharmacologic treatment options
  203. Assay of mixtures of phenylpropanolamine hydrochloride and caffeine in appetite suppressant formulations by high-performance liquid chromatography
  204. Assessment of carprofen and buprenorphine on recovery of mice after surgical removal of the mammary fat pad
  205. Assessment of redox state and biochemical parameters of salivary glands in rats treated with anti-obesity drug sibutramine hydrochloride
  206. Assessment of the mechanism of neurotoxicity of 3, 4-methylenedioxy methamphetamine (MDMA)
  207. Assessment of the Relationship Between Physical Behaviours, Psychological Factors, Medication Use, Body Composition and Weight Regain Following Bariatric …
  208. Association between breakfast skipping and body weight—A systematic review and meta-analysis of observational longitudinal studies
  209. Association between water consumption and body weight outcomes: a systematic review
  210. Associations between dental problems and underweight status among rural women in Burkina Faso: results from the first WHO Stepwise Approach to Surveillance …
  211. Associations between Weight Loss-Induced Changes in Plasma Organochlorine Concentrations, Serum T3 Concentration, and Resting Metabolic Rate
  212. Autophagy Regulates the Immune Phenotype of Human Adipose-Derived Stem Cells and Alters Their Therapeutic Efficacy in a Mouse Model of Multiple Sclerosis
  213. Available online through ISSN: 2319-5622 www. jprinfo. com A Review on Herbal Approach towards the Treatment of Obesity
  214. Avenca: Nature’s Secret for Weight Loss
  215. AYURVEDIC MEDICINES USED IN MANAGEMENT OF MEDOROG (OVERWEIGHT AND OBESITY): A REVIEW
  216. Baclofen suppresses alcohol intake and craving for alcohol in a schizophrenic alcohol-dependent patient: a case report
  217. Barriers to health care utilization: The effect of the medical stigma of” obesity” on women
  218. Baseline traits as predictors of success in medical weight management
  219. Beat Overeating Now!: Take Control of Your Hunger Hormones to Lose Weight Fast
  220. Behavioral and neuronal interactions between sucrose and nicotine in female rats
  221. Behavioral and pharmacologic treatment of obesity
  222. Beliefs and behaviors of college students toward weight management
  223. Beneficial Effect of Dietary Supplements on Metabolic-Induced Obesity
  224. Beneficial effects of carob pulp (Ceratonia siliqua) on lipids profile and oxidant/antioxidant status in obese rats
  225. Beneficial effects of fennel (Foeniculum vulgare) in treating obesity in rats
  226. Beneficial effects of Hibiscus sabdariffa and Lippia citriodora extracts on diet-induced obesity in mice: potential treatments for metabolic syndrome
  227. Beneficial effects of hydro-alcoholic extract of Caralluma fimbriata against high-fat diet-induced insulin resistance and oxidative stress in Wistar male rats
  228. Benefits of nut consumption on insulin resistance and cardiovascular risk factors: multiple potential mechanisms of actions
  229. Berberine ameliorates obesity by inducing GDF15 secretion by brown adipocytes
  230. Berberine for appetite suppressant and prevention of obesity
  231. Berberine for Appetite Suppressant and Prevention of Obesity
  232. Berberine is as effective as the anti-obesity drug Orlistat in ameliorating betel-nut induced dyslipidemia and oxidative stress in mice
  233. Berberine treatment for weight gain in patients with schizophrenia by regulating leptin rather than adiponectin
  234. Best Natural Appetite Suppressants for Weight Loss in 2022
  235. Best OTC Appetite Suppressants in 2022: Over the Counter Hunger Control Pills and Supplements that Work
  236. Beta Hydroxybutyrate, Insulin, Leptin, Glucose, Lipid Profile, and Anthropometric Measurements as a predictor of Weight Changes among Palestinian Obese Adult …
  237. Beverages containing soluble fiber, caffeine, and green tea catechins suppress hunger and lead to less energy consumption at the next meal
  238. Beyond appetite regulation: Targeting energy expenditure, fat oxidation, and lean mass preservation for sustainable weight loss
  239. Bifidobacteria and its rice fermented products on diet induced obese mice: Analysis of physical status, serum profile and gene expressions
  240. Binding of hepatic nuclear proteins from obese and lean Zucker rats to the upstream region of malic enzyme gene
  241. Bioactive C21 Steroidal Glycosides from the Roots of Cynanchum otophyllum That Suppress the Seizure-like Locomotor Activity of Zebrafish Caused by …
  242. Bioactive food stimulants of sympathetic activity: effect on 24-h energy expenditure and fat oxidation
  243. Bioactive peptides from Atlantic salmon (Salmo salar) with angiotensin converting enzyme and dipeptidyl peptidase IV inhibitory, and antioxidant activities
  244. Bioactivity-Guided Isolation and Identification of Anti-adipogenic Constituents from the n-Butanol Fraction of Cissus quadrangularis
  245. Biochemical Studies in Genetically Obese Rodents
  246. Biochemical testing for neuroendocrine tumors
  247. Biomaterials that regulate fat digestion for the treatment of obesity
  248. BIRD’ S EYE VIEW ON HERBAL MARKET PRODUCTS IN INDIA FOR THE TREATMENT OF OBESITY
  249. Body Fuel: Calorie-cycle Your Way to Reduced Body Fat and Greater Muscle Definition
  250. Body weight management in overweight and obese breast cancer survivors
  251. Body weight regulation: Essential knowledge to lose weight and keep it off
  252. Bofutsushosan use for obesity with IGT: search for scientific basis and development of effective therapy with Kampo medicine
  253. BOFUTSUSHOSAN” KAMPO MEDICINE” USE IN METABOLIC SYNDROME: RESEARCH THE SCIENTIFIC BASIS AND CLINICAL TRIAL IN JAPANESE OBESITY
  254. Botanicals as medicinal food and their effects against obesity
  255. Brain alterations related to tobacco smoking: target points for prevention and intervention
  256. Brain Arachidonic Acid Incorporation and Precursor Pool Specific Activity During Intravenous Infusion of Unesterified [3H]Arachidonate in the Anesthetized Rat
  257. Brain CB2 Receptors: Implications for Neuropsychiatric Disorders
  258. Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine: a systematic review of the evidence
  259. Brain Serotonin Receptor Messenger RNA in the Functional Psychoses
  260. Brain serotonin transporter occupancy by oral sibutramine dosed to steady state: A PET study using 11C-DASB in healthy humans
  261. Brain-derived neurotrophic factor signaling does not stimulate subventricular zone neurogenesis in adult mice and rats
  262. Brainstorming: The science and politics of opiate research
  263. Brown adipose tissue energy metabolism in humans
  264. Browning effects of (-)-epicatechin on adipocytes and white adipose tissue
  265. Buprenorphine suppresses cocaine self-administration by rhesus monkeys
  266. Bupropion for weight reduction
  267. Caffeine with links to NAFLD and accelerated brain aging
  268. Caffeine–rich infusion from Cola nitida (kola nut) inhibits major carbohydrate catabolic enzymes; abates redox imbalance; and modulates oxidative dysregulated …
  269. Caffeine, coffee, and appetite control: a review
  270. Calcium, dairy products, and energy balance in overweight adolescents: a controlled trial
  271. Caloric restriction, physical exercise, and CB1 receptor blockade as an efficient combined strategy for bodyweight control and cardiometabolic status …
  272. Calorie restriction â an approach towards obesity management
  273. Can gut hormones control appetite and prevent obesity?
  274. Can the FUT 2 Gene Variant Have an Effect on the Body Weight of Patients Undergoing Bariatric Surgery?—Preliminary, Exploratory Study
  276. Can we win the war on obesity with pharmacotherapy?
  277. Canary Seed (Phalaris canariensis L.) Peptides Prevent Obesity and Glucose Intolerance in Mice Fed a Western Diet
  278. Canine obesity–an overview
  279. Cannabidiol for the treatment of brain disorders: therapeutic potential and routes of administration
  280. Cannabinoids and terpenes for diabetes mellitus and its complications: from mechanisms to new therapies
  281. Cannabinoids delivery systems based on supramolecular inclusion complexes and polymeric nanocapsules for treatment of neuropathic pain
  282. Cannabis and the brain
  283. Capsaicin for weight control:“Exercise in a pill”(or just another fad)?
  284. Capsaicinoids and capsinoids. A potential role for weight management? A systematic review of the evidence
  285. Capsaicinoids–a potential role for weight management
  286. Caralluma dalzielii Ethanolic Extract Prevents High-fat-diet-induced Obesity in Mice
  287. Caralluma fimbriata and metformin protection of rat pancreas from high fat diet induced oxidative stress
  288. Cardiovascular and psychiatric risk profile and patterns of use in patients starting anti‐obesity drugs
  289. Casearin D inhibits ERK phosphorylation and induces downregulation of cyclin D1 in HepG2 cells
  290. Catecholamine neurons
  291. CB1 and GLP-1 receptors cross talk provides new therapies for obesity
  292. CB1 cannabinoid receptor in SF1-expressing neurons of the ventromedial hypothalamus determines metabolic responses to diet and leptin
  293. Central nervous system stimulants and drugs that suppress appetite
  294. Central Nervous System Stimulants and Drugs That Suppress Appetite
  295. Certified personal trainers and physicians: An evaluation of consumer preference, influence, and decision making on intent to use a weight-loss medication
  296. Challenges in personalized evidence-based medicine, applications in type 2 diabetes
  297. Characterisation of an acute anorexigenic action of l-tryptophan: a link with neural mechanisms regulating appetite
  298. Characterization of different subpopulations of hypothalamic POMC neurons in the regulation of energy balance.
  299. Characterization of phentermine and related compounds as monoamine oxidase (MAO) inhibitors
  300. Characterization of the Anti-Obesity and Anti-Adipogenic Effects of the Limonoid Prieurianin
  301. Characterization of the synergistic effects of cocaine with lateral hypothalamic brain stimulation reward
  302. Chemical composition and in vitro antiobesity and in vivo anti-hyperlipidemic effects of Ceratotheca sesamoides, Jatropha tanjorensis, Mucuna flagellipes …
  303. Chemical isolation of novel compounds from Spirulina with anti-obesity activity as future nutraceuticals
  304. Chemo-structural diversity of anti-obesity compound database
  305. Childhood obesity–A public health crisis across the European Union
  306. Chinese herbal medicine for the treatment of people with impaired glucose tolerance and insulin resistance
  307. Cholecystokinin and D-fenfluramine inhibit food intake in oxytocin-deficient mice
  308. Chromatographic fingerprinting through chemometric techniques for herbal slimming pills: A way of adulterant identification
  309. Chronic amphetamine treatment reduces NGF and BDNF in the rat brain
  310. Chronic consumption of food-additives lead to changes via microbiota gut-brain axis
  311. Chronic ephedrine administration decreases brown adipose tissue activity in a randomised controlled human trial: implications for obesity
  312. Chronic ephedrine administration decreases brown adipose tissue activity in a randomised controlled human trial: implications for obesity
  313. Chronic Fluoxetine Treatment Suppresses Plasticity (Long-Term Potentiation) in the Mature Rodent Primary Auditory Cortex In Vivo
  314. CILI Weight Loss Spray
  315. Circadian misalignment of the 24-hour profile of endocannabinoid 2-arachidonoylglycerol (2-AG) in obese adults
  316. Clinical and biological perspectives of non-antipsychotic psychotropic medications and weight gain
  317. Clinical implications of appetite suppressants
  318. Co-agonist of glucagon and GLP-1 reduces cholesterol and improves insulin sensitivity independent of its effect on appetite and body weight in diet-induced obese …
  319. Coacervate whey protein improves inflammatory milieu in mice fed with high-fat diet
  320. Codonopsis lanceolata Extract Prevents Diet-Induced Obesity in C57BL/6 Mice
  321. Combination of very low energy diets and pharmacotherapy in the treatment of obesity: meta‐analysis of published data
  322. Combination Therapies for Obesity
  323. Combined Anti-Adipogenic Effects of Hispidulin and p-Synephrine on 3T3-L1 Adipocytes
  324. Commonly prescribed oral anti-obesity medication and alternative anorectics
  325. Comparative biomolecular and therapeutic effectiveness of collaborative integrative intervention in morbidly obese individuals
  326. Comparative effects of intraduodenal infusions of lauric and oleic acids on antropyloroduodenal motility, plasma cholecystokinin and peptide YY, appetite, and energy …
  327. Comparison of the Effects of Two Oat-based Cereals on Appetite and Satiety, and the Effect of a Fat Emulsion of Appetite, Satiety, Food Intake, and Body …
  328. Complementary and alternative therapies for weight loss
  329. Complementary medicine therapies that may assist with weight loss: a narrative review
  330. Comprehensive review on herbal medicine for energy intake suppression
  331. Computational approaches to predicting treatment response to obesity using neuroimaging
  332. Concise handbook of psychoactive herbs: medicinal herbs for treating psychological and neurological problems
  333. Confessions of a Fat Cosmo Girl: How I Lost 122 Pounds & Kept It Off & How You Can Too
  334. Constant craving: What your food cravings mean and how to overcome them
  335. Contemporary approaches into obesity: Drugs and genes
  336. Control of blood pressure, appetite, and glucose by leptin in mice lacking leptin receptors in proopiomelanocortin neurons
  337. Controlling diet experience of diabetic patients in Bukittinggi, Indonesia
  338. Cotreatment with racemic fenfluramine inhibits the development of tolerance to morphine analgesia in rats
  339. Could capsaicinoids help to support weight management? A systematic review and meta-analysis of energy intake data
  340. Cross-talk between DHEA and neuropeptides
  341. Cross-Talk between Obesity and Diabetes: Introducing Polyphenols as an Effective Phytomedicine to Combat the Dual Sword Diabesity
  342. Cultivation practices and manufacturing processes to produce Hoodia gordonii extract for weight management products
  343. Curcumin mimics the neurocognitive and anti-inflammatory effects of caloric restriction in a mouse model of midlife obesity
  344. Current and investigational antiobesity agents and obesity therapeutic treatment targets
  345. Current and potential drugs for treatment of obesity
  346. Current anti-diabetic agents and their molecular targets: A review
  347. Current evidence to propose different food supplements for weight loss: A comprehensive review
  348. Current Insights on the Use of Insulin and the Potential Use of Insulin Mimetics in Targeting Insulin Signalling in Alzheimer’s Disease
  349. Current pharmacotherapy for obesity
  350. Current pharmacotherapy for weight loss: a review and implications for plastic surgeons
  351. Current strategies in the development of anti-obesity drugs and their safety concerns
  352. Cyclin-dependent kinase 4 is a preclinical target for diet-induced obesity
  353. Cysteine protease inhibitors from the methanol extract of the root bark of Securidaca longepedunculata with antimalarial potentials in chloroquine-resistant P …
  354. Dangerous herbal weight-loss supplements
  355. De-Stress, Weigh Less: A Six-Step No-Diet Plan For Relaxing Your Way To Permanent Weight Loss
  356. Defatted safflower seed extract inhibits adipogenesis in 3T3-L1 preadipocytes and improves lipid profiles in C57BL/6J ob/ob mice fed a high-fat diet
  357. Defective insulin signalling, mediated by inflammation, connects obesity to Alzheimer disease; relevant pharmacological therapies and preventive dietary …
  358. Defining Predictors of Weight Loss Response to Lorcaserin
  359. Derivatives of 1, 4-bis (3-hydroxycarbonyl-4-hydroxyl) styrylbenzene as PTP1B inhibitors with hypoglycemic activity
  360. Design and rationale of the Utah obesity study. A study to assess morbidity following gastric bypass surgery
  361. Design and synthesis of selective serotonin agonists for the therapeutic treatment of obesity
  362. Design, Synthesis and Biological Evaluation of Novel GPR-119 Agonist for the Treatment of Type 2 Diabetes Mellitus
  363. Design, synthesis, and biological activity of substituted 2-amino-5-oxo-5H-chromeno [2, 3-b] pyridine-3-carboxylic acid derivatives as inhibitors of the inflammatory …
  364. Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitors
  365. Detection and determination of undeclared synthetic caffeine in weight loss formulations using HPLC-DAD and UHPLC-MS/MS
  366. Detection and verification of sibutramine adulterated in herbal slimming supplements using electrospray ionization mass spectrometry
  367. Determinants of low birthweight and perinatal mortality in Central Sudan with special reference to malaria
  368. Determination of PDE-5 inhibitors and appetite suppressants in adulterated dietary supplements using LC/PDA and LC/MS
  369. Determination of the Appetite Suppressant P57 in Hoodia gordonii Plant Extracts and Dietary Supplements by Liquid Chromatography/Electrospray Ionization Mass …
  370. Determining the clinical and economic impact of intensive weight-loss management in adults with severe obesity using a Markov microsimulation model
  371. Determining the Influence of Endocannabinoids in Skeletal Muscle Adiponectin sensitivity in Diet Induced Obesity and Diabetes
  372. Determining the Sensitivity of Gustatory Neurons in the Maxillary Styloconic Sensilla of Gypsy Moth Larvae
  373. Development and evaluation of antiobesity Polyherbal formulation
  374. Development and evaluation of antiobesity polyherbal granules: a full spectrum weight management concept
  375. Development of a multidiscipline approach to assess feed deprivation in swine using physiological, behavioral, neurological, and pharmacological methods
  376. Devil’s Claw to Suppress Appetite—Ghrelin Receptor Modulation Potential of a Harpagophytum procumbens Root Extract
  377. Diabetes and herbal (botanical) medicine
  378. Diabetes at Your Fingertips
  379. Diet composition and perceptions around food in individuals with Type 2 Diabetes Mellitus following a long-term low carbohydrate high fat diet
  380. Diet or exercise, or both, for preventing excessive weight gain in pregnancy
  381. Diet-induced gut dysbiosis and inflammation: key drivers of obesity driven NASH
  382. Diet, neurochemicals, and mental energy
  383. Diet, nutrition, and obesity
  384. Dietary fat and cholesterol in the pathogenesis of obesity and non-alcoholic fatty liver disease
  385. Dietary Fiber and Obesity
  386. Dietary influences on the microbiota–gut–brain axis
  387. Dietary patterns and cardiovascular disease risk in people with type 2 diabetes
  388. Dietary Strategies to Influence Appetite: Effects of Oat Beta-Glucan and Thylakoids from Spinach on Satiety and Reward-induced Eating Behavior
  389. Dietary supplements for obesity
  390. Dietary treatment of obesity
  391. Differential changes in plasma high-density lipoprotein-cholesterol levels in obese men and women during weight reduction
  392. Differential effects of d-fenfluramine and p-chloroamphetamine on H7512-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain
  393. Differential expression of factors involved in fat metabolism with age and the menopause transition
  394. Differential expression of rat pancreatic islet beta-cell glucose transporter (GLUT 2), proinsulin and islet amyloid polypeptide genes after prolonged fasting, insulin …
  395. Differential regulation of rat insulin I and II messenger RNA synthesis: effects of fasting and cyproheptadine
  396. Differentiation of the effects of protein status and acid-base balance on the appetite of sheep for lucerne silage
  397. Dioscorea dumetorum-fed rats exhibited decreased body weight, blood glucose, and insulin in stz-induced diabetes
  398. Direct and indirect effects of obestatin peptides on food intake and the regulation of glucose homeostasis and insulin secretion in mice
  399. Discovery of arginine-containing tripeptides as a new class of pancreatic lipase inhibitors
  400. Discovery of novel compounds from cyanobacteria for the treatment of obesity
  401. Disease state management: Obesity-sugar, fat or carbs?
  402. DNA Microarray Technology in the Evaluation of Weight Management Potential of a Novel Calcium-Potassium Salt of (—)-Hydroxycitric Acid
  403. Do Neurotrophins Play a Role in Adult Neurogenesis?
  404. Do Obese and Nonobese Consumers Respond Differently to Price Changes? Implications of Preference Heterogeneity for Using Food Taxes and Subsidies to …
  405. Does neuropeptide Y contribute to the anorectic action of amylin?
  406. Does Preconception Alcohol Abuse Make the Offspring Vulnerable to Developing Type II Diabetes?
  407. Dose-dependent effects of cholecystokinin-8 on antropyloroduodenal motility, gastrointestinal hormones, appetite, and energy intake in healthy men
  408. Double immunofluorescent evidence that oxidative stress-associated activation of JNK/AP-1 signaling participates in neuropeptide-mediated appetite control
  409. Down-regulation of microglial activation may represent a practical strategy for combating neurodegenerative disorders
  410. Dr Luc’s Promise: Lose the weight and keep it off
  411. DRF 2655: a unique molecule that reduces body weight and ameliorates metabolic abnormalities
  412. Drinking extra water or other non‐caloric beverages for promoting weight loss or preventing weight gain
  413. Drop The Fat Act and Live Lean
  414. Drug strategies for the treatment of obesity
  415. Drug therapy for obesity in the elderly
  416. Drug therapy of obesity in children
  417. Drug treatment of obesity
  418. Drug treatment of obesity: from past failures to future successes?
  419. Drugs of Abuse and Addiction: neurobehavioral toxicology
  420. Duodenal fatty acid sensor and transporter expression following acute fat exposure in healthy lean humans
  421. Dynamics in health care utilisation in patients prior to initiation of anti-obesity drug use
  422. E-cigarettes and weight loss—product design innovation insights from industry patents
  423. Eat Fat, Get Fit: How to Create Your Perfect Diet to Lose Weight, Heal Your Gut, and Have More Energy
  424. Eat Yourself Clever: A 28-Day Plan to Help you Lose Weight, Improve Brain Power and Boost Wellbeing
  425. Eat, Sleep And Slim With Honey: The new scientific breakthrough
  426. Edible plants, their secondary metabolites and antiobesogenic potential
  427. Effect of acupoint embedding on serum leptin and hypothalamus leptin receptor expression in rats with simple obesity
  428. Effect of Bergenia crassifolia L. extracts on weight gain and feeding behavior of rats with high-caloric diet-induced obesity
  429. Effect of branched-chain amino acids on food intake and indicators of hunger and satiety-a narrative summary
  430. Effect of Caralluma Fimbriata Extract on 3T3-L1 Pre-Adipocyte Cell Division
  431. Effect of Caralluma fimbriata extract on appetite and lipid profile in rats fed with hypercalorie/cafeteria diet
  432. Effect of Caralluma fimbriata extract on appetite, body weight & lipid profile in cafeteria diet-induced obesity in rats
  433. Effect of Caralluma fimbriata extract on appetite, food intake and anthropometry in adult Indian men and women
  434. Effect of chronic administration of fenfluramine and quipazine on body weight gain after ovariectomy and on brain serotonin receptor binding.
  435. Effect of Coleus forskohlii extract on cafeteria diet-induced obesity in rats
  436. EFFECT OF CONSUMING BROWN RICE BARS CONTAINING Hoodia gordonii AND Kappaphycus alvarezii ON GLYCEMIC INDEX, APPETITE AND FOOD INTAKE …
  437. Effect of Crude Extract of Khat (Catha Edulis) On the Plasma Glucose Level of Normoglycemic and STZ Induced Type 2 Diabetic Rats
  438. Effect of cubic phase nanoparticle on obesity-suppressing efficacy of herbal extracts
  439. Effect of exercise and common obesity single nucleotide polymorphisms on appetite and appetite-regulatory hormones
  440. Effect of fenugreek on type 2 diabetic patients
  441. Effect of GLP-1 receptor agonists on obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis.
  442. Effect of green coffee bean extract on steroid hormones synthesis, blood lipids and body weight in rats
  443. Effect of green tea extract on food consumption and body weight in experimentally-induced myocardial infarction in adult male albino rat
  444. Effect of herbal product on the body weight reduction in high fat diet-induced obese Sprague Dawley Rats/Chai Swee Fern
  445. Effect of low-calorie ketogenic vs low-carbohydrate diets on body composition and other biomarkers of overweight/obese women: An 8 weeks randomised controlled …
  446. Effect of Macrotyloma uniflorum on antiobesity in rats fed with a high fat diet
  447. Effect of Nelumbo nucifera Petal Extracts on Lipase, Adipogenesis, Adipolysis, and Central Receptors of Obesity
  448. Effect of Nicotine on Dopamine and Glutathione Levels in Presence of Oligoelements in Brain Regions of Young Rats——Effect of Nicotine on Brain Regions of Rat
  449. Effect of nutrition and exercise education on obese women taking sibutramine
  450. Effect of oleoylethanolamide on systemic inflammation in the development of alimentary-induced obesity in mice
  451. Effect of orlistat alone or in combination with Garcinia cambogia on visceral adiposity index in obese patients
  452. Effect of phenylpropanolamine on energy expenditure and weight loss in overweight women
  453. Effect of Polyglucosamine on Weight Loss and Metabolic Parameters in Overweight and Obesity: A Systematic Review and Meta-Analysis
  454. Effect of Polyglucosamine on Weight Loss and Metabolic Parameters in Overweight and Obesity: A Systemic Review and Meta-Analysis
  455. Effect of repeated administration of dexfenfluramine on feeding and brain Fos in mice
  456. Effect of serotonin reuptake inhibitors on pulmonary hemodynamics in humans
  457. Effect of Short Term Sibutramine Supplementation on Appetite Suppression and Related Metabolic Responses
  458. Effect of small intestinal nutrient infusion on appetite, gastrointestinal hormone release, and gastric myoelectrical activity in young and older men
  459. Effect of subcutaneous injections of PYY1-36 and PYY3-36 on appetite, ad libitum energy intake, and plasma free fatty acid concentration in obese males
  460. Effect of Supplemented Food with Wild Mango (Irvingia Smithii) Almond Powder on the Weight Growth of Mice
  461. Effect of synbiotic supplementation in a Very‐Low‐Calorie ketogenic diet on weight loss achievement and gut microbiota: a randomized controlled pilot study
  462. Effect of the herbal medicines in obesity and metabolic syndrome: a systematic review and meta‐analysis of clinical trials
  463. Effect of the slimming agent oleoyl-estrone in liposomes on the body weight of rats fed a cafeteria diet
  464. Effect of Usnic Acid (UA) and Conjugated Linoleic Acid (CLA) on Adiposity and BodWeight of Ratsies
  465. Effect of vaccination against gonadotrophin-releasing factor on growth performance, carcass, meat and fat quality of male Duroc pigs for dry-cured ham production
  466. Effective interventions in overweight or obese young children: systematic review and meta-analysis
  467. Effectiveness of Medifast supplements combined with obesity pharmacotherapy: a clinical program evaluation
  468. Effectiveness of Obesity Management
  469. Effects of 15-d repeated consumption of Hoodia gordonii purified extract on safety, ad libitum energy intake, and body weight in healthy, overweight women: a …
  470. Effects of 3.5 GHz radiofrequency radiation on ghrelin, nesfatin-1, and irisin level in diabetic and healthy brains
  471. Effects of anti-obesity drugs, phentermine and mahuang, on the behavioral patterns in Sprague-Dawley rat model
  472. Effects of balanced deep‐sea water on adipocyte hypertrophy and liver steatosis in high‐fat, diet‐induced obese mice
  473. Effects of body weight levels on Cannabis self-injection
  474. Effects of cannabidiol on growth performance, appetite, antioxidant capacity and liver inflammatory gene expression of juvenile large yellow croaker (Larmichthys …
  475. Effects of canola proteins and hydrolysates on adipogenic differentiation of C3H10T/2 mesenchymal stem cells
  476. Effects of Chronic Electronic Vapor Exposure on Body Weight, Appetite, and Metabolism
  477. Effects of chronic vanadate administration in the STZ-induced diabetic rat: the antihyperglycemic action of vanadate is attributable entirely to its suppression of feeding
  478. Effects of Combined Training on the Levels of Obestatin, Ghrelin, and Insulin Resistance in Overweight Women
  479. Effects of diet on body weight, body composition, metabolic status, and physical activity levels of adult female dogs after spay surgery
  480. Effects of diet on body weight, body composition, metabolic status, and physical activity of adult female dogs after spay surgery
  481. Effects of dietary carbohydrate to lipid ratios on growth, biochemical indicators, lipid metabolism, and appetite in Chinese perch (Siniperca chuatsi)
  482. Effects of dietary polyphenols on neuroregulatory factors and pathways that mediate food intake and energy regulation in obesity
  483. Effects of different stressors are modulated by different neurobiological systems: the role of GABA-A Versus CB1 receptor gene variants in anxiety and …
  484. Effects of estrogen replacement and chronic PGHS-2 inhibition on vascular function in the aged rat.
  485. Effects of Ethanol Extracts from Grateloupia elliptica, a Red Seaweed, and Its Chlorophyll Derivative on 3T3-L1 Adipocytes: Suppression of Lipid Accumulation …
  486. Effects of herbal drink on overweight among young adult women
  487. Effects of IL-6 signaling pathway inhibition on weight and BMI: a systematic review and meta-analysis
  488. Effects of Jia Wei Dachaihu-Tang on gut microbiota and inflammatory markers in patients with overweight or obesity: study protocol for a randomized, controlled …
  489. Effects of Komouni Formulation (Herbal Product of Persian Medicine) With a Low-Calorie Diet on Cardiometabolic Risk Factors in Overweight and Obese …
  490. Effects of L-phenylalanine on energy intake and glycaemia—impacts on appetite perceptions, gastrointestinal hormones and gastric emptying in healthy males
  491. Effects of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 on Overweight and the Gut Microbiota in Humans: Randomized, Double …
  492. Effects of Maclura tricuspidata (Carr.) Bur fruits and its phytophenolics on obesity‐related enzymes
  494. Effects of polyphenols on thermogenesis and mitochondrial biogenesis
  495. Effects of repeated injection of neem leaf extract and restraint stress on a model of anxiety and brain serotonin metabolism in rats
  496. Effects of sex steroids and diet on adipose distribution and cardiovascular disease risk factors
  497. Effects of sodium-glucose co-transporter-2 inhibitors on anthropometric indices and metabolic markers in overweight/obese individuals without diabetes: a systematic …
  498. Effects of the crude extract from the fruit rind of rambutan (nephelium lappaceum l.) on obesity in male wistarrats
  499. Efficacy and Acceptance of a Commercial Hoodia parviflora Product for Support of Appetite and Weight Control in a Consumer Trial
  500. Efficacy and safety of Chinese herbal medicine and acupuncture in the management of obesity: systematic reviews and a randomised placebo-controlled clinical trial
  501. Efficacy and Safety of Combined Extracts of Cornus officinalis and Ribes fasciculatum for Body Fat Reduction in Overweight Women
  502. Efficacy and safety of Euiiyin-tang in Korean women with obesity: a randomized, double-blind, placebo-controlled, multicenter trial
  503. Efficacy and safety of once-weekly semaglutide in adults with overweight or obesity: a meta-analysis
  504. Efficacy and safety of the new appetite suppressant, liraglutide: a meta-analysis of randomized controlled trials
  505. Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials
  506. Efficacy of calcium supplementation for management of overweight and obesity: systematic review of randomized clinical trials
  507. Efficacy of Garcinia Cambogia as adjuvant in the treatment of obesity and associated diseases. Adv Nutri and Food Scie: ANAFS-168
  508. Efficacy of herbal supplements containing Citrus aurantium and synephrine alkaloids for the management of overweight and obesity: a systematic review
  509. Efficacy of Hoodia gordonii extract as a weight loss supplement: a comparative study between an invertebrate, Tenebrio molitor (Coleoptera: Tenebrionidae), and a …
  510. Efficacy of low-carbohydrate ketogenic diet in the treatment of type 2 diabetes
  511. Efficacy, Safety and Epidemiology of Anti-Obesity Drug Prescribing in Children and Adolescents
  512. Electrophysiological evidence for concurrent appetitive and defensive motivational system activation in cue-induced tobacco cravings
  513. Elucidating the Neurotoxic Effects of Piperazine Derivatives in Human Neuroblastoma Cells through Oxidative Stress, Mitochondrial Dysfunction and Apoptosis
  514. Emerging antiobesity drugs
  515. Endocannabinoids in appetite control and the treatment of obesity
  516. Endocannabinoids in the regulation of appetite and body weight
  517. Endocrinology of the Gut and the Regulation of Body Weight and Metabolism
  518. Energy balance and regulation of body weight after intestinal bypass surgery in rats
  519. Energy drinks, weight loss, and disordered eating behaviors
  520. Enhanced brain biodistribution of Ginsenoside Rg1 based self-nanoemulsifying drug delivery system to ameliorate metabolic syndromes and keep homeostatic …
  521. Enhanced nicotine self‐administration and suppressed dopaminergic systems in a rat model of diabetes
  522. Ephedra-Treated Donor-Derived Gut Microbiota Transplantation Ameliorates High Fat Diet-Induced Obesity in Rats
  523. Ephedrine reduces weight of viable yellow obese mice (Avy/a)
  524. Epigenetic regulation of adipogenesis in development of metabolic syndrome
  525. Epigenetics of obesity: DNA methylation in single white blood cell types
  526. Essential oil of Pinus koraiensis inhibits cell proliferation and migration via inhibition of p21-activated kinase 1 pathway in HCT116 colorectal cancer cells
  527. Estradiol treatment increases M2-like visceral adipose tissue macrophages in obese ovariectomized mice regardless of its anorectic action
  528. Ethanol and the Female Brain: Estrogen as a Regulator of Ethanol Reward and Drinking Behavior
  529. Ethnobotanical study and effect on mice weight gain of four plants used during famine in Burkina Faso: Raphionacme daronii, Gardenia erubescens, Leptadenia …
  530. Ethnobotanical study of medicinal plants used as anti-obesity remedies in the nomad and hunter communities of Burkina Faso
  531. Ethnobotanical Survey of Appetite Suppressant Plants Used in Hauts-Bassins Areas of Burkina Faso
  532. Ethnobotanical survey of medicinal plants used to manage high blood pressure and type 2 diabetes mellitus in Bitterfontein, Western Cape Province, South Africa
  533. Ethnobotanical survey of plants used in the Mmanagement of obesity in Ibadan, south-western Nigeria
  534. Ethnobotanical treatments of diabetes in Baja California Norte
  535. Ethnobotanical, micrographic and pharmacological features of plant-based weight-loss products sold in naturist stores in Mexico City: the need for better …
  536. Etiologies of obesity
  537. Evaluation of Anti-obesity Potentials of Phenolic-Rich Fraction of Solanum aethiopicum L. and Solanum macrocarpon L on Diet-induced Obesity in Wistar Rats
  538. Evaluation of antiobesity activity of various plant extracts
  539. Evaluation of antioxidant, anti-inflammatory and adipocyte differentiation inhibitory potential of Ziziphus mauritiana bark extract
  540. Evaluation of interactions between CCK and GLP-1 in their effects on appetite, energy intake, and antropyloroduodenal motility in healthy men
  541. Evaluation of Neurological Efficacy of Some Novel Heterocyclics
  542. Evaluation of phendimetrazine bitartrate as an appetite suppressant
  543. Evaluation of the content and quality of information advertised on retail websites marketing herbal weight loss supplements in the United States
  544. Evaluation of the relationship between Body Mass Index (BMI) and healthcare cost, utilization and health-related quality of life in adult diabetic patients
  545. Evidence for a hijacked brain reward system but no desensitized threat system in quitting‐motivated smokers: An fMRI study
  546. Evidence for the efficacy and safety of herbal weight loss preparations
  547. Evidence for the use of appetite suppressant drugs in Brazil: a pharmacoeconometric study
  548. Evidence of anti-obesity effects of the pomegranate leaf extract in high-fat diet induced obese mice
  549. Evidence-based Clinical Chinese Medicine-Volume 27: Overweight And Obesity In Adults
  550. Examination of Dechlorinating Anaerobic Microbes in Poly-chlorinated Biphenyl Contaminated Sediments in the Chesapeake Bay
  551. Examining the associations of smoking behavior and obesity among older adults in China: Should we consider food consumption behaviors?
  552. Examining the link between maternal nutrition, gestational weight gain, and later offspring health
  553. Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised …
  554. Exercise-induced recovery of skeletal muscle insulin response is independent of adiponectin response in high-fat fed rodents
  555. Exogenous administration of spermine improves glucose utilization and decreases bodyweight in mice
  556. Exogenous GDF11, but not GDF8, reduces body weight and improves glucose homeostasis in mice
  557. Experiences of Health Care Practitioners in caring for children with overweight and obesity
  558. Exploiting anti-obesity mechanism of Clerodendrum phlomidis against two different models of rodents.
  559. Exploiting common aspects of obesity and cancer cachexia for future therapeutic strategies
  560. Exploration of body weight regulation by polyunsaturated fatty acids in rat: potential association with hypothalamic neurogenesis
  561. Exploring the Patient Experience of Changes in Appetite and Diet with Incretin Analogue Therapy
  562. Exploring the role of dopamine neurons in salt intake
  563. Exposure to a high-fat diet decreases sensitivity to Δ9-tetrahydrocannabinol-induced motor effects in female rats
  564. Expression of leptin and β3-adrenergic receptors in rat adipose tissue in altered thyroid states
  565. Expression, purification, and functional characterization of potato proteinase inhibitor type II (PI2)
  566. Extensive review of popular functional foods and nutraceuticals against obesity and its related complications with a special focus on randomized clinical trials
  567. Extra virgin olive oil intake and the lower likelihood of being obese, hypertensive and diabetic
  568. EXTRACT IN THE PREVENTION AND TREAMENT OF OBESITY
  569. Factitious thyrotoxicosis and herbal dietary supplement for weight reduction
  570. Factors associated with ventilatory failure in obesity
  571. Fast and portable voltammetric method for the determination of the amphetamine adulterant ephedrine in natural over-the-counter weight-loss products
  572. Fat and bone: an odd couple
  573. Fat Church
  574. Fat Flush for Life: The Year-round Super Detox Plan to Boost Your Metabolism and Keep the Weight Off Permanently
  575. Fat Nation: a history of obesity in America
  576. Fat no more: The answer for the dangerously overweight
  577. Fat, Gluttony and Sloth: Obesity in Literature, Art and Medicine
  578. FAT…. It’s Not All That: Two Main Types of Fat in Our Bodies, Visceral and Subcutaneous Fat
  579. Fatty acid nitroalkenes ameliorate glucose intolerance and pulmonary hypertension in high-fat diet-induced obesity
  580. FDA-approved anti-obesity drugs in the United States
  581. Features, prevention and management of acute overdose due to antidiabetic drugs
  582. Feed Your Brain, Lose Your Belly: A Brain Surgeon Reveals the Weight-Loss Secrets of the Brain-Belly Connection
  583. Fen-Phen Litigation Against American Home Products Corporation: The Widespread Use of Fenfluramine (Pondimin) and Dexfenfluramine (Redux) for Weight Loss …
  584. Fenfluramine-induced immunosuppression: an in vivo analysis
  585. Fermentable and nonfermentable fiber supplements did not alter hunger, satiety or body weight in a pilot study of men and women consuming self-selected diets
  586. Fermentable Non-Digestible Dietary Fiber and Bioactive Compounds Affect Aging and Fat Deposition in Caenorhabditis Elegans
  587. Fifth IBRO World Congress of Neuroscience, Jerusalem, Israel, July 11-15, 1999
  588. Focusing on new monoamine oxidase inhibitors
  589. Food and Drug Administration’s obesity drug guidance document: a short history
  590. Food fads and fallacies regarding weight loss in obese teens and adolescents
  591. Forebrain neurochemical interactions and circuitry involved in effort-related choice
  592. Forensic Identification of CITES Protected Slimming Cactus (Hoodia) Using DNA Barcoding
  593. Formulation and Evaluation of Polyherbal Syrup with Anti-diabetic activity
  594. Forskolin reduces fat accumulation in Nile tilapia (Oreochromis niloticus) through stimulating lipolysis and beta-oxidation
  595. Freeze-dried jaboticaba peel powder improves insulin sensitivity in high-fat-fed mice
  596. FTO gene expression in diet-induced obesity is downregulated by Solanum fruit supplementation
  597. Fucoxanthin alleviates methamphetamine-induced neurotoxicity possibly via the inhibition of interaction between Keap1 and Nrf2
  598. Functional foods against metabolic syndrome (obesity, diabetes, hypertension and dyslipidemia) and cardiovasular disease
  599. Functional heterogeneity of POMC neurons relies on mTORC1 signaling
  600. Functional properties of Claramine: A novel PTP1B inhibitor and insulin-mimetic compound
  601. Garcina Kola neuroprotective effects on the prefrontal cortex cyto-architecture of MDMA-induced neuroinflammation in male Wistar rats model
  602. Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial
  603. Garcinia cambogia and Glucomannan reduce weight, change body composition and ameliorate lipid and glucose blood profiles in overweight/obese patients
  604. Garcinia cambogia for weight loss
  605. Gary Null’s Ultimate Lifetime Diet: A Revolutionary All-natural Program for Losing Weight and Building a Healthy Body
  606. Gastroesophageal Motility and Reflux Following Bariatric Surgery for the Treatment of Severe Obesity
  607. Gastrointestinal hormones regulating appetite
  608. Gastrointestinal Nutrient Sensing in Obesity and Type 2 Diabetes: Role in Appetite Regulation and Glycaemic Control
  609. GC-MS Profile, α-glucosidase Inhibition Potential, Antibacterial and Antioxidant Evaluation of Peels Citrus aurantium (L), Essential Oil
  610. Gene expression signatures associated with suppression of TRAMP prostate carcinogenesis by a kavalactone‐rich Kava fraction
  611. Genetic analysis of extreme obesity
  612. Ghrelin interacts with neuropeptide Y Y1 and opioid receptors to increase food reward
  613. Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ
  614. Ghrelin, obestatin and the ghrelin/obestatin ratio as potential mediators for food intake among obese children: a case control study
  615. Ginger water reduces body weight gain and improves energy expenditure in rats
  616. Glucagon and the control of appetite
  617. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects
  618. Glyphosate’s suppression of cytochrome P450 enzymes and amino acid biosynthesis by the gut microbiome: pathways to modern diseases
  619. Green tea reduces body fat via upregulation of neprilysin
  620. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus
  621. Guidelines for the initiation of obesity treatment
  622. Gut fat signaling and appetite control with special emphasis on the effect of thylakoids from spinach on eating behavior
  623. Gut microbiota and metabolomic changes associated to the beneficial effects of polyphenols on obesity
  624. Gut microbiota mediates the anti-obesity effect of calorie restriction in mice
  625. Gut microbiota modulate the metabolism of brown adipose tissue in mice
  626. Gut Reactions: The Science of Weight Gain and Loss
  627. Gymnema Sylvestre plant used by peoples of Vidisha district for the treatment of diabetes
  628. Habitual coffee consumption and changes in measures of adiposity: a comprehensive study of longitudinal associations
  629. Halogenated mazindol analogs as potential inhibitors of the cocaine binding site at the dopamine transporter
  630. Heavy: The obesity crisis in cultural context
  631. Hepatic insulin resistance in ob/ob mice involves increases in ceramide, aPKC activity, and selective impairment of Akt-dependent FoxO1 phosphorylation
  632. Herbal and dietary supplements for weight loss
  633. Herbal and microbial products for the management of obesity
  634. Herbal and Microbial Products for the Management of Obesity
  635. Herbal Antiobesity Products and Their Function in the Gut-Brain Axis
  636. Herbal approach for obesity management
  637. Herbal delivery system for treatment of obesity administration of encapsulated khat-extracts on body weight of rats
  638. Herbal drugs and herbal substances for regulation of the body weight
  639. Herbal medicine for obesity treatment: a review
  640. Herbal medicines applied to obesity.
  641. Herbal medicines for suppressing appetite: A systematic review of randomized clinical trials
  643. Herbal nanotherapy: A new paradigm over conventional obesity treatment
  644. Herbal preparations for obesity: are they useful?
  645. Herbal weight loss supplements: from dubious efficacy to direct toxicity
  646. Herbal-derived anti-obesity compounds and their action mechanisms
  647. Herbals used for diabetes, obesity, and metabolic syndrome
  648. HERBS AND MEDICINAL PLANTS FOR CURING OBESITY AND RELATED COMPLICATIONS: A REVIEW
  649. Herbs for Obesity: A Review
  650. High and low carbohydrate and fat intakes: limits imposed by appetite and palatability and their implications for energy balance
  651. High incidence of primary pulmonary hypertension associated with appetite suppressants in Belgium
  652. High performance liquid chromatography with fluorescence detection for the determination of phenylpropanolamine in human plasma and rat’s blood and brain …
  653. High-throughput screening for selective appetite modulators: A multibehavioral and translational drug discovery strategy
  654. Historical framework for the development of ideas about obesity
  655. Hoodia gordonii extract targets both adipose and muscle tissue to achieve weight loss in rats
  656. Hoodia gordonii in the treatment of obesity: A review
  657. Hoodia gordonii: A natural appetite suppressant
  658. Hoodia gordonii: an up-to-date review of a commercially important anti-obesity plant
  659. Hoodia: A herb used in South African traditional medicine–A potential cure for overweight? Pharmacognostic review of history, composition, health-related …
  660. Hot & heavy: Fierce fat girls on life, love & fashion
  661. Hot, tired and hungry: the snacking behaviour and food cravings of firefighters during multi-day simulated wildfire suppression
  662. How Advantra Z and Chromax Work Together to Support Weight Loss
  663. How Long Have Supplements Promised to Make Us Slim, Sexy, and Virile?
  664. How not to diet: the groundbreaking science of healthy, permanent weight loss
  665. How safe is the use of herbal weight-loss products sold over the Internet?
  666. How to Lose Weight with Hypnosis
  667. How we eat: appetite, culture, and the psychology of food
  668. Huangjinya Black Tea Alleviates Obesity and Insulin Resistance via Modulating Fecal Metabolome in High‐Fat Diet‐Fed Mice
  669. Human genomics and obesity: finding appropriate drug targets
  670. Human obesity: its hormonal basis and the role of gastric inhibitory polypeptide
  671. Hunger as ideology
  672. Hunger is more than an empty stomach
  673. Hunter-gatherers win profit-sharing deal for obesity drug.
  674. Hypericum silenoides Juss. and Hypericum philonotis Cham. & Schlecht. extracts: in-vivo hypolipidaemic and weight-reducing effects in obese rats
  675. Hyperphagia-mediated obesity in transgenic mice misexpressing the RNA-editing enzyme ADAR2
  676. Hypothalamic beta-endorphin, body weight, and food intake in ovarian steroid treated rats
  677. Hypothalamic endocannabinoids in obesity: an old story with new challenges
  678. Hypothalamic neuropeptide Y (NPY) and the attenuation of hyperphagia in streptozotocin diabetic rats treated with dopamine D1/D2 agonists
  679. Hypothalamic neuropeptide Y (NPY) gene expression is not affected by central serotonin in the rainbow trout (Oncorhynchus mykiss)
  680. I’m a Celebrity, Don’t Get Me out of Here: How Law and Celebrity Advocacy Can Protect Young People from Miracle Weight Loss Products’ Advertising on Social …
  681. Identification and determination of synthetic pharmaceuticals as adulterants in eight common herbal weight loss supplements
  682. Identification of novel PTP1B inhibitors by pharmacophore based virtual screening, scaffold hopping and docking
  683. Identification of Weight Loss Supplement Cha De Bugre
  684. Imatinib attenuates hypoxia-induced pulmonary arterial hypertension pathology via reduction in 5-hydroxytryptamine through inhibition of tryptophan hydroxylase 1 …
  685. Immunohistochemical and genomic evidence for the involvement of hypothalamic neuropeptide Y (NPY) in phenylpropranolamine-mediated appetite suppression
  686. Immunostimulatory effect of ketogenic diet in cyclophosphamide-induced immunosuppression in adult albino rats
  687. Impact of depression on co-morbid diabetes in primary care
  688. Impact of ketosis on appetite regulation—a review
  689. Impact of Maternal Obesity and Diabetes on Long-Term Health of the Offspring
  690. Impact of the herbal medicine, Ephedra sinica stapf, on gut microbiota and body weight in a diet-induced obesity model
  691. Impact of Weight Loss on Serum Leptin in Obese Postmenopausal Women
  692. Impacts of psychotropic pharmaceuticals on hybrid striped bass: altered predation behavior as a function of changes in brain chemistry
  693. IMPAIRED GHRELIN SECRETION IN OBESITY: THE KEY ROLE OF INSULIN RESISTANCE
  694. Impenetrable bodies/disappearing bodies: Fat American celebrities, lean indigenous people, and multinational pharmaceuticals in the battle to claim Hoodia gordonii
  695. Implementation and Evaluation of the MOVE! Program at Medical Weight Loss Center
  696. Implicating the effect of ketogenic diet as a preventive measure to obesity and diabetes mellitus
  697. Implication of coronin 7 in body weight regulation in humans, mice and flies
  698. Importance of reward and prefrontal circuitry in hunger and satiety: Prader–Willi syndrome vs simple obesity
  699. Improving fitness: Mapping research priorities against societal needs on obesity
  700. Improving Media Literacy: An In-Depth Look at Consumer Perspectives of Weight-Loss Supplement Advertisements on Instagram
  701. Improving Provider Identification and Management of Overweight and Obesity in Primary Care
  702. in Obesity: The Cause or the Effect?
  703. In search of an ideal drug for safer treatment of obesity: The false promise of pseudoephedrine
  704. IN SILICO AND IN VITRO SCREENING OF MARRUBIIN AND MARRUBIIN DERIVATIVES FOR ANTIDIABETIC ACTIVITY ON PTP1β, C2C12 MYOCYTES …
  705. In vitro & in nivo anti-adipogenic effects of a standardized quassinoid composition from Eurycoma longifolia/Dharvind Balan
  706. In vitro investigation of the potential health benefits of wild Mediterranean dietary plants as anti‐obesity agents with α‐amylase and pancreatic lipase inhibitory …
  707. In vitro toxicity of weight-loss supplements conjugated linoleic acid Levo-carnitine and hydroxycitric acid
  708. In vivo antidiabetic activity and safety in rats of Cissampelos pareira traditionally used in the management of diabetes mellitus in Embu County, Kenya
  709. In Vivo Effects of Raspberry Ketone (4-(4-Hydroxyphenyl)-Butan-2-One) as a Supplement for Weight Loss in Mice
  710. In-vitro screening of selected traditional medicinal plants for their anti-obesity and anti-oxidant activities
  711. Incidence of β3-adrenergic receptor polymorphism and prediction of successful weight reduction with mazindol therapy in severely obese Japanese subjects
  712. Increase in plasma pollutant levels in response to weight loss is associated with the reduction of fasting insulin levels in men but not in women
  713. Increased neuropeptide Y concentrations in specific hypothalamic regions of streptozocin-induced diabetic rats
  714. Increased PUFA content and 5-lipoxygenase pathway activity are associated with sub-cutaneous adipose tissue inflammation in obese women
  715. Incretin-based therapies in prediabetes: current evidence and future perspectives
  716. Indigenous use of Hoodia gordonii and appetite suppression
  718. Individual Risk Factors and Appetite Response to Obesogenic Environment as Correlates and Predictors of Binge Eating Among College Students
  719. Individualized Diabetes Management: A Guide for Primary Care
  720. Indole-based fibrates as potential hypolipidemic and antiobesity agents
  721. Inference of Brain States from Frontal Electroencephalography And Pupillometry During General Anaesthesia
  722. Inflammation markers in adipose tissue and cardiovascular risk reduction by pomegranate juice in obesity induced by a hypercaloric diet in Wistar rats
  723. Influence of Amphetamine-type stimulants in the Central Nervous System: abuse and neurotoxicity
  724. Influence of eating behaviors on short-term weight loss by orlistat and anorectic agent
  725. Influence of hunger and satiety on perceived pleasantness and intensity ratings of food and nonfood odors as a function of locus of control
  726. Influence of resistant starch from potatoes on glycemic response in healthy, overweight females
  727. Ingredient options for weighty formulations: the” 2010 Prepared Foods’ R&D Trends: Weight Management Formulations” survey investigates product developers’ …
  728. Inhibition and down regulation of the serotonin transporter contribute to the progression of degenerative mitral regurgitation
  729. Inhibition of cannabinoid receptor 1 can influence the lipid metabolism in mice with diet-induced obesity
  730. Inhibition of Cytochrome P450 by Constituents from Blue Cohosh (Caulophyllum thalictroides)
  731. Inhibition of drug‐induced anorexia in rats by methysergide
  732. Inhibition of food intake induced by acute stress in rats is due to satiation effects
  733. Inhibition of gut-and lung-derived serotonin attenuates pulmonary hypertension in mice
  734. Inhibition of IKK-β: A new development in the mechanism of the anti-obesity effects of PTP1B inhibitors SA18 and SA32
  735. Inhibition of key enzymes linked to obesity by preparations from Mediterranean dietary plants: effects on α-amylase and pancreatic lipase activities
  736. Inhibition of lipid droplet accumulation by Solanum nigrum by suppressing adipogenesis and inducing lipolysis, thermogenesis and autophagy in 3T3‑L1 cells
  737. Inhibition of ovarian cancer cell proliferation by oleoylethanolamide and its metabolically stable analog AM3102
  738. Inhibition of pancreatic lipase by poloxamer 407 may provide an adjunct treatment strategy for weight loss
  739. Inhibition of phosphoenolpyruvate carboxykinase activity appears to be the key biochemical lesion in the acute toxicity of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in rats
  740. Inhibition of Protein Tyrosine Phosphatase-Sigma Promotes Hematopoietic Stem Cell Regeneration
  741. Inhibition of PTP1B by farnesylated 2-arylbenzofurans isolated from Morus alba root bark: unraveling the mechanism of inhibition based on in vitro and in …
  742. Inhibition of the adrenergic phenotype in cultured neural crest cells by norepinephrine uptake inhibitors
  743. Inhibition of the norepinephrine transporter by the venom peptide χ-MrIA: Site of action, Na+ dependence, and structure-activity relationship
  744. Inhibitor design for monoamine oxidases
  745. Inhibitors of fatty acid synthesis in prokaryotes and eukaryotes as anti-infective, anticancer and anti-obesity drugs
  746. Inhibitors of preadipocyte replication: opportunities for the treatment of obesity
  747. Insight into appetite and blood glucose regulation in anorexia nervosa and health: Examining gastrointestinal changes in starvation and with short-term refeeding
  748. Insulin resistance and hypersecretion in obesity
  749. Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review
  750. Integrative approaches to obesity treatment
  751. Integrative Health and Medicine: Dietary Supplements and Modalities for the Treatment of Obesity
  752. Interaction of smoking and obesity susceptibility loci on adolescent BMI: The National Longitudinal Study of Adolescent to Adult Health
  753. Interactions of flavone and steroid from A. subintegra as potential inhibitors for porcine pancreatic lipase
  754. Interactions with drugs and dietary supplements used for weight loss
  755. Interventions for preventing excessive weight gain during pregnancy
  756. Interventions for preventing weight gain after smoking cessation
  757. Interventions for treating children and adolescents with overweight and obesity: an overview of Cochrane reviews
  758. Interventions for treating overweight or obesity in adults: an overview of systematic reviews
  759. Interventions for weight loss in people with chronic kidney disease who are overweight or obese
  760. Interventions to reduce weight gain in schizophrenia
  761. Intestinal regulation of hunger and reward. Studies with thylakoids.
  762. Intracerebral administration of protein kinase A or cAMP response element-binding protein antisense oligonucleotide can modulate amphetamine-mediated appetite …
  763. INTRACRANIAL INFUSIONS OF NEUROTENSIN AGONISTS PRODUCE AN ANXIOLYTIC PROFILE IN A RAT ULTRASONIC VOCALIZATION MODEL
  764. Intragastric injections of partially digested triglyceride suppress feeding in the rat
  765. Investigating the effect of sex and ketosis on weight-loss-induced changes in appetite
  766. Investigating the effects of an acute dose of benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) alone and in combination on the human brain using …
  767. Investigating the effects of mycoprotein on glycaemic control and appetite in South Asian and white European adults with type 2 diabetes
  768. Investigating the role of thiosulfate sulfurtransferase in adipose tissue dysfunction in obesity
  769. Investigation of Orlistat as an intervention for obesity and cardiovascular risk factors: A systematic review
  770. Investigation of the behavioral processes and neurobiological substrates involved in the motivation for voluntary wheel running in the rat
  771. Investigation of the cholecystokinin-beta receptor, IL-27, IL-27, gene SNP and some biochemical parameters in patients with type-1 diabetes mellitus
  772. Investigation of the physiological mechanisms regulating appetite and food intake humans
  773. Investigations into the gastrointestinal control of appetite and nutritional frailty.
  774. Investigations into the gastrointestinal factors involved in the regulation of appetite and energy intake
  775. Investigations of the Mechanisms of Diabetes Remission: A Focus on Adaptive Thermogenesis
  776. Involvement of oxidative stress in the regulation of NPY/CART-mediated appetite control in amphetamine-treated rats
  777. Involvement of YAP/TAZ Signaling Pathway in Anti-obesity Activity of Moringa oleifera Leaf Extract
  778. IQP‐GC‐101 reduces body weight and body fat mass: a randomized, double‐blind, placebo‐controlled study
  779. Is activation of human brown adipose tissue a viable target for weight management?
  780. Is pulmonary arterial hypertension in neurofibromatosis type 1 secondary to a plexogenic arteriopathy?
  781. Isolation and Characterization of Contaminating Bacteria from Garcinia cambogia Extract: Methods to Reduce Microbial Load and Its Anti-Obesity Effect in …
  782. Isolation and identification of a novel anti-diabetic compound from Euclea undulata Thunb
  783. Japanese traditional Kampo medicine bofutsushosan improves body mass index in participants with obesity: A systematic review and meta-analysis
  784. Javalution: Fitness and Weight Loss Through Functional Coffee
  785. Ketogenic Diet and Exercise Intervention in Obesity: Cardiometabolic Health and Gut Microbiota
  786. Khat (Catha edulis) and Obesity: A Scoping Review of Animal and Human Studies
  787. Khat (Catha edulis) upregulates lipolytic genes in white adipose tissue of male obese mice (C57BL/6J)
  788. Khat use and appetite: an overview and comparison of amphetamine, khat and cathinone
  789. Knockdown of the transcript of ERK in the brain modulates hypothalamic neuropeptide‐mediated appetite control in amphetamine‐treated rats
  790. Known Clinical Epigenetic Disorders with an Obesity Phenotype: Prader–Willi Syndrome and the GNAS Locus
  791. Kojic acid repurposing as a pancreatic lipase inhibitor and the optimization of its production from a local Aspergillus oryzae soil isolate
  792. Lactobacillus alleviated obesity induced by high‐fat diet in mice
  793. Late-onset neuroleptic malignant syndrome in a patient using olanzapine
  794. Le Personal Coach: A French Trainer’s Simple Secrets for Getting Fit and Slim without the GymRenewing Your Body
  795. Leanbean Review: Fat Burner Ingredients, Where to Buy Pills, Side Effects
  796. Leanbean Reviews 2023: Legit Fat Burner or Scam? Ingredients, Benefits, Side Effects, and More
  797. Leptin Administration Prevents Spontaneous Gestational Diabetes in Heterozygous Leprdb/+ Mice: Effects on Placental Leptin and Fetal Growth
  798. Leptin and Insulin Modulate Nutrient Partitioning and Weight Loss in ob/ob Mice through Regulation of Long-Chain Fatty Acid Uptake by Adipocytes
  799. Leptin prevents insulin resistance induced by conjugated linoleic acid in obese mice
  800. Leptin resistance contributes to obesity and hypertension in mouse models of Bardet-Biedl syndrome
  801. Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene
  802. Leptin: a new therapeutic target for treatment of diabetes mellitus
  803. Leptin’s Role in the Obesity Epidemic
  804. Lesser investigated natural ingredients for the management of obesity
  805. Lifestyle changes: effect of diet, exercise, functional food, and obesity treatment on lipids and lipoproteins
  806. Lines, dashed lines and “scale” ex-tricks. Objective measurements of appetite versus subjective tests of intake
  807. Lipase inhibitors for obesity: A review
  808. Lipid induced macrophage inflammation: implications for obesity induced insulin resistance
  809. Lipolytic effect of compounds isolated from leaves of mulberry (Morus alba L.) in 3T3-L1 adipocytes
  810. Lipophilic amines as potent inhibitors of N-acylethanolamine-hydrolyzing acid amidase
  811. Lipopolysaccharide-induced strain-specific differences in neuroinflammation and MHC-I pathway regulation in the brains of Bl6 and 129Sv mice
  812. Liquid chromatography–high resolution mass spectrometry (LC–HRMS) determination of stimulants, anorectic drugs and phosphodiesterase 5 inhibitors (PDE5I) in …
  813. Liraglutide therapy in a prediabetic state: rethinking the evidence
  814. Liraglutide, a glucagon-like peptide-1 analog, in individuals with obesity in clinical practice
  815. List of drugs in development for neurodegenerative diseases
  816. List of drugs in development for neurodegenerative diseases
  817. Literature review: anti-diabetic potential of some selected edible vegetables in tropical region
  818. Living the Raw Live Vegan Lifestyle: Finally Eat More and Lose More Weight with Optimal Nutrition!
  819. Long term successful weight loss with a combination biphasic ketogenic Mediterranean diet and Mediterranean diet maintenance protocol
  820. Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials
  821. Lose weight wisely and naturally
  822. Losing Weight with Your Diabetes Medication: How Byetta and Other Drugs Can Help You Lose More Weight Than You Ever Thought Possible
  823. Low protein diet supplemented with crystalline amino acids suppressing appetite and apo-lipoprotein synthesis in laying hens
  824. Lysosome vacuolation disrupts the completion of autophagy during norephedrine exposure in SH-SY5Y human neuroblastoma cells
  825. Malonyl-CoA, fuel sensing, and insulin resistance
  826. Management of Diabetes and Its Complications with Banaba (Lagerstroemia speciosa L.) and Corosolic Acid
  827. Management of obesity: pharmacotherapy
  828. Management of the obese patient undergoing office-based oral and maxillofacial surgery procedures1
  829. Managing obesity like any other chronic condition: Long-term therapy may reduce comorbidity as well
  830. Managing obesity through natural polyphenols: A review
  831. Manganese exacerbated chronic khat-induced neurological deficits, inflammation and organ toxicity in a mouse model
  832. marked neurodegeneration. Thus, NO, whether endogenously generated via NO synthase following NMDA receptor activation
  833. marked neurodegeneration. Thus, NO, whether endogenously generated via NO synthase following NMDA receptor activation
  834. Marked transaminase elevations and worsening glycemic control associated with counterfeit polyherbal use in a patient with diabetes
  835. Master Your Metabolism: The All-natural (all-herbal) Way to Lose Weight
  836. Mate tea (Ilex paraguariensis) promotes satiety and body weight lowering in mice: involvement of glucagon-like peptide-1
  837. Maternal Adiposity Alters Transcriptomic and Epigenomic Neurodevelopmental Landscapes in the Fetal Hippocampus
  838. Maternal docosahexanoic acid supplementation increases adiponectin expression in intrauterine growth restricted rats
  839. Maternal effects on the neuroimmune response in the adult rat
  840. Maternal risk factors for low birth weight at South rand hospital (Johannesburg)
  841. Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter
  842. Measures of glucose homeostasis during and after duodenal exclusion using a duodenal-jejunal bypass liner in a normoglycemic, nonobese canine model
  843. Mechanisms of action for the anti-obesogenic activities of phytochemicals
  844. Mechanisms of body weight reduction by black tea polyphenols
  845. Mechanisms of insulin resistance and β-cell failure in type 2 diabetes. Effective diet against o minous octet
  846. Mechanisms of neurotransmitter release by amphetamines: a review
  847. MECHANISTIC EFFECT OF DIETARY COMPONENTS IN MANAGING OBESITY
  848. Medical and Endoscopic Therapy of Obesity
  849. Medical history of obesity
  850. Medical management of obesity in Scandinavia 2016
  851. Medicinal plants and natural products: More effective and safer pharmacological treatment for the management of obesity
  852. Medicinal plants and their inhibitory activities against pancreatic lipase: a review
  853. Medicinal plants for diabetes associated neurodegenerative diseases: A systematic review of preclinical studies
  854. Medicinal plants for the treatment of Obesity
  855. Medicinal plants with acetylcholinesterase inhibitory activity
  856. Medium-chain triglycerides reduce glomerulosclerosis and induce expression of redox genes in NSY mice with diabetic nephropathy
  857. Medium-Chain Triglycerides Reduce Glomerulosclerosis and Induce Redox Genes Level of NSY Mice with Diabetic Nephropathy
  858. Melanocortin-4 receptor mRNA is expressed in sympathetic nervous system outflow neurons to white adipose tissue
  859. Menthol cigarette smoking and obesity in young adult daily smokers in Hawaii
  860. Mentors in motion: A physical activity intervention for obese adolescents
  861. Meta-analysis of change in weight and heart rate for phentermine in obesity
  862. Metabolic and epigenetics action mechanisms of antiobesity medicinal plants and phytochemicals
  863. Metabolic and lifestyle profiling of overweight female runners compared to lean counterparts: exploring the implications and causes of their elevated body weight
  864. Metabolic changes in diet-induced obesity among rats treated with ethanol extract of Alternanthera sessilis red
  865. Metabolic effect of short term administration of Hoodia gordonii, an herbal appetite suppressant
  866. Metabolic effects in C57BL/6J mice fed a high-fat diet supplemented with Pinot noir juice and wine extract or quercetin, ellagic acid and resveratrol
  867. Metabolic gene signature in white adipose tissue of oral doses raspberry ketone [4-(4-hydroxyphenyl)-2-butanone] that prevent diet-induced weight gain and induce …
  868. Metabolic profiling and identification of biomarkers for weight loss
  869. Metabolic syndrome and obesity among users of second generation antipsychotics: A global challenge for modern psychopharmacology
  870. Metabolic tinkering by the gut microbiome: Implications for brain development and function
  871. Metabolic, behavioral and neurochemical studies of 3, 4-methylenedioxy analogues of amphetamine
  872. Methamphetamine-induced neurotoxicity in cultured astrocytes
  873. Methcathinone “kitchen chemistry” and permanent neurological damage
  874. Method Validation for the Analysis of Multiple Weight Loss Drugs in Dietary Supplement Materials by LC-MS/MS
  875. Microbiota intestinal; relevancia para la obesidad y la modulación de los prebióticos y probióticos
  876. Microscopic Analyzing of the Herbal Teas Sold In Pharmacy for Losing Weight
  877. Microsomal prostaglandin E synthase-1 deficiency attenuates the development of diet-induced obesity
  878. Microwave-assisted extraction and differential scanning calorimetry in the chemical identification of sliming agents apprehended in the south region of Brazil
  879. Miracle of Herbals and Natural Products in Treatment and Regulation of Obesity
  880. Misconceptions and misleading information prevail-Less regulation does not mean less danger to consumers: Dangerous herbal weight loss products
  881. Mitigation of Obesity: A Phytotherapeutic Approach
  882. Modern concept of obesity treatment
  883. Modulation of fat digestion using bioactive alginates
  884. Modulation of Metabolic Reprogramming in Macrophage Impacts the Pathogenesis of Insulin Resistance and Type II Diabetes
  885. Modulation of neuropeptide W on gastric vagal afferents.
  886. Modulatory effects of Caralluma fimbriata extract against high-fat diet induced abnormalities in carbohydrate metabolism in Wistar rats
  887. Molecular matchmaking between the popular weight-loss herb Hoodia gordonii and GPR119, a potential drug target for metabolic disorder
  888. Monoamine oxidase inhibition is unlikely to be relevant to the risks associated with phentermine and fenfluramine: a comparison with their abilities to evoke …
  889. Monoamine oxidase inhibitors: a review concerning dietary tyramine and drug interactions
  890. Moringa oleifera offers a multi-mechanistic approach for management of obesity in rats
  891. mTORC1 pathway disruption abrogates the effects of the ciliary neurotrophic factor on energy balance and hypothalamic neuroinflammation
  892. Multi targeted strategies towards identification of potential drug candidates from natural products in the management of obesity
  893. Multiple target of hAmylin on rat primary hippocampal neurons
  894. Multistep Inhibition of α-Synuclein Aggregation and Toxicity in Vitro and in Vivo by Trodusquemine
  895. Myocardial glucose clearance by aspalathin treatment in young, mature, and obese insulin-resistant rats
  896. Mystery of the Cure: The Intermittent Fasting Revelation How Science and the Bible Have Uncovered the Mystery of Good Health and Weight Loss
  897. N-docosahexaenoyl, 3 hydroxytyramine: a dopaminergic compound that penetrates the blood-brain barrier and suppresses appetite
  898. NANETS consensus guidelines for the diagnosis of neuroendocrine tumor
  899. Natural anti-obesity agents
  900. Natural anti-obesity agents and their therapeutic role in management of obesity: A future trend perspective
  901. Natural Compounds Promoting Weight Loss: Mechanistic Insights from the Point of View of the Medicinal Chemist
  902. Natural Compounds–Anti-Obesity Properties
  903. Natural dietary and herbal products in anti-obesity treatment
  904. Natural dietary products and their effects on appetite control
  905. Natural products in anti-obesity therapy
  906. Natural products: a safest approach for obesity
  907. Network analyses reveal negative link between changes in adipose tissue GDF15 and BMI during dietary-induced weight loss
  908. Neural Integration of Peripheral Signals Implicated in the Control of Energy Homeostasis and Metabolism: Phenotype of neurons in the nucleus of the solitary …
  909. Neurochemical effects of 3, 4-methylenedioxymethamphetamine (MDMA) and its metabolites in animals and cell culture models
  910. Neurochemical regulators of food behavior for pharmacological treatment of obesity: current status and future prospects
  911. Neurocognitive effects of methamphetamine: a critical review and meta-analysis
  912. Neuroimaging to study brain reward processing and reward-based learning in binge eating pathology
  913. Neurologic Emergencies from Recreational Substances
  914. Neuromodulation of Dahlgren Cell Activity in the Caudal Neurosecretory System of a Euryhaline Teleost
  915. Neuronal protein tyrosine phosphatase 1B hastens amyloid β-associated Alzheimer’s disease in mice
  916. Neuropeptide regulation of appetite and weight
  917. Neuropeptide Y promoter polymorphism modifies effects of a weight-loss diet on 2-year changes of blood pressure: the preventing overweight using novel dietary …
  918. Neuropharmacological effects of low and high doses of repeated oral dexfenfluramine in rats: a comparison with fluoxetine
  919. Neuropharmacological properties of the cathinones
  920. Neuroprotective effects of Co-ultraPEALut on inflammatory process induced by traumatic brain injury
  921. Neuroprotective effects of voluntary exercise and monoaminergic modulators in stressed male rats
  922. Neuropsychiatric pharmaceuticals and illicit drugs in wastewater treatment plants: a review
  923. Neuropsycho-Cardiologic Risks Associated with Menopausal Women–Benefits of a Plant Based Formulation
  924. Neuropsychopharmacological and behavioural mechanisms underlying eating behaviour and disordered eating behaviour
  925. Neurotensin: Evidence for a role in satiety
  926. New advances in models and strategies for developing anti-obesity drugs
  927. New and Promising Drugs for Obesity
  928. New dietary supplements for obesity: What we currently know
  929. New insights into potential nutritional effects of dietary saponins in protecting against the development of obesity
  930. New oxypregnane glycosides from appetite suppressant herbal supplement Hoodia gordonii
  931. New perspectives on the development of antiobesity drugs
  932. New therapeutic options for the management of diabetes
  933. New trends in medicinal chemistry approaches to antiobesity therapy
  934. New Zealand bitter hops extract reduces hunger during a 24 h water only fast
  935. Nicotine addiction and overweight affect intrinsic neural activity and neurotransmitter activity: A fMRI study of interaction effects
  936. Nicotine and energy balance: A review examining the effect of nicotine on hormonal appetite regulation and energy expenditure
  937. Nipsnap1—A Regulatory Factor Required For Long-Term Maintenance of Non-Shivering Thermogenesis
  938. Nitric oxide as a target for phytochemicals in anti-neuroinflammatory prevention therapy
  939. No effect of Momordica charantia Linn on glycemic regulation, energy expenditure and appetite in healthy overweight men: A pilot study
  940. Nonclinical assessment of the potential for herb-drug interactions between herbal extracts present in weight loss supplements and lamotrigine
  941. Nonclinical assessment of the potential for herb-drug interactions between herbal extracts present in weight loss supplements and lamotrigine
  942. Nonsurgical and surgical treatment of obesity
  943. Normal food intake and body weight in mice lacking the G protein-coupled receptor GPR39
  944. Novel anti-obesity peptide (RLLPH) derived from hazelnut (Corylus heterophylla Fisch) protein hydrolysates inhibits adipogenesis in 3T3-L1 adipocytes by regulating …
  945. Novel antiobesity agents: Synthesis and pharmacological evaluation of analogues of Rimonabant and of LH21
  946. Novel broccoli-derived peptides hydrolyzed by trypsin with dual-angiotensin i-converting enzymes and dipeptidyl peptidase-iv-inhibitory activities
  947. Novel Lipids to Regulate Obesity and Brain Function: Comparing Available Evidence and Insights from QSAR In Silico Models
  948. Novel Obesity Suppressor Function of the Retinoblastoma Protein Uncovers Cyclindependent Kinase 4 as a Therapeutic Target for Diet-Induced Obesity
  949. Nucleobindin-2 (NUCB2) gene transcription activity and nesfatin-1 levels in correlation with anthropometric and biochemical parameters in type 2 diabetes mellitus …
  950. Nutraceutical supplements for weight loss: a systematic review
  951. Nutrients, obesity and gene expression
  952. Nutrition and weight control for longevity
  953. Nutritionist and obesity: brief overview on efficacy, safety, and drug interactions of the main weight-loss dietary supplements
  954. Obesitiy: Its Complications and Available Medications
  955. Obesity (Primer)
  956. OBESITY 20 jUL m
  957. Obesity algorithm eBook, presented by the Obesity Medicine Association
  958. Obesity and Appetite Drugs
  959. Obesity and cardiovascular disease
  960. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss
  961. Obesity and clinical riskiness relationship: therapeutic management by dietary antioxidant supplementation—a review
  962. Obesity and Diabetes
  963. Obesity and energy balance: is the tail wagging the dog?
  964. Obesity and gut microbiota
  965. Obesity and heart disease: a statement for healthcare professionals from the Nutrition Committee, American Heart Association
  966. Obesity and Herbal Drug Research: Exploring the Safer Alternative and Lead Molecule
  967. Obesity and lifestyle-related disorders beyond the stethoscope: Role of botanicals
  968. Obesity and non-alcoholic fatty liver-therapies in ayurvedic medicines
  969. Obesity and related disorders
  970. Obesity and Type 2 Diabetes: Adiposopathy as a Triggering Factor and Therapeutic Options
  971. Obesity and Weight Loss
  972. Obesity as a Neurobiologic Disorder: A Heavyweight Contender
  973. Obesity Associated Dementia Among Elderly–Role of a Plant Based Formulation
  974. Obesity in adults: Drug therapy
  975. Obesity in neurobiology
  976. Obesity induced dysfunction of gastric vagal afferent signalling.
  977. Obesity Medicine
  978. Obesity pharmacotherapy: current perspectives and future directions
  979. Obesity pharmacotherapy: what is next?
  980. Obesity phytotherapy: review of native herbs used in traditional medicine for obesity
  981. Obesity related alterations in plasma cytokines and metabolic hormones in chimpanzees
  982. Obesity surgery and gut–brain communication
  983. Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins
  984. Obesity, altered oxidative stress, and clinical correlates in chronic schizophrenia patients
  985. Obesity, metabolic syndrome, and cardiovascular disease
  986. Obesity, sleep apnea, and hypertension
  987. Obesity: a chronic disease in need of drug targets and safe medicines
  988. Obesity: An Overview
  989. Obesity: an overview on its current perspectives and treatment options
  990. Obesity: evaluation and treatment
  991. Obesity: the biography
  992. Obesity: the preventive role of the pomegranate (Punica granatum)
  993. Obesity: The Venus of Willendorf
  994. One Size Does Not Fit All: A Qualitative Study Exploring Unlicensed Weight Loss Drug Use In Women
  995. Onion (Allium cepa L.) peel extract effects on 3T3-L1 adipocytes and high-fat diet-induced obese mice
  996. Optimization of the extract from flower of Citrus aurantium L. var. amara Engl. and its inhibition of lipid accumulation
  997. Oral Administration of Hoodia parviflora Alleviates Insulin Resistance and Nonalcoholic Steatohepatitis
  998. Oral leucine supplementation is sensed by the brain but neither reduces food intake nor induces an anorectic pattern of gene expression in the hypothalamus
  999. Oroxylum indicum (L.) Kurz extract inhibits adipogenesis and lipase activity in vitro
  1000. OTC Slimming Aids
  1001. Outsmart Your Genes: How Understanding Your DNA Will Empower You to Protect Yourself Against Cancer, A lzheimer’s, Heart Disease, Obesity, and Many …
  1002. Over-the-counter weight loss preparations
  1003. Over-the-counter Weight-Loss Herbal Supplements in Egypt: Label Claim, Microbiological, Pharmaceutical Quality and Safety Assessments
  1004. Overeating and obesity from damage to a noradrenergic system in the brain
  1005. Overview and the Future of Obesity Treatment
  1006. Overview of pharmacologic treatment of obesity: Past experiences, present options, and future directions
  1007. Overweight and obesity
  1008. Overweight, obesity and adiposity in survivors of childhood brain tumours: a systematic review and meta‐analysis
  1009. Overweight, obesity and older Australians: understanding the social context
  1010. Oxytocin as an appetite suppressant that reduces feeding reward
  1011. Oxytocin’s Regulation of Thermogenesis May Be the Link to Prader–Willi Syndrome
  1012. PACAP intraperitoneal treatment suppresses appetite and food intake via PAC1 receptor in mice by inhibiting ghrelin and increasing GLP-1 and leptin
  1013. Paediatric obesity, inflammation & asthma
  1014. Paeoniflorin ameliorates chronic hypoxia/SU5416-induced pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition
  1015. Pancreatic lipase inhibition by papaverine: investigation by simulated molecular docking and subsequent in vitro evaluation
  1016. Pancreatic lipase inhibitors from natural sources: unexplored potential
  1017. Pancreatic lipase inhibitory and antioxidative constituents from the aerial parts of Paeonia lactiflora Pall.(Ranunculaceae)
  1018. Part I: Design, synthesis, and studies of novel age-inhibitors and age-breakers; Part II: Novel synthetic methods for organofluorine compound
  1019. Participation of ghrelin signalling in the reciprocal regulation of hypothalamic NPY/POMC-mediated appetite control in amphetamine-treated rats
  1020. Pathogenesis of type 2 diabetes mellitus
  1021. Pediatric obesity psychopharmacology: Quo vadis?
  1022. Pediatric obesity: Current concepts
  1023. Perceptions and experiences of women in Benoni regarding weight loss strategies
  1024. Performance of PLS, GA-PLS and OSC-GA-PLS Models in QSAR Study of Pyrazolone Derivatives Inhibitory Activity, and Image Processing for New Compounds …
  1025. Periodic health examination, 1999 update: 1. Detection, prevention and treatment of obesity
  1026. Peroxisome proliferator-activated receptor γ attenuates serotonin-induced pulmonary artery smooth muscle cell proliferation and apoptosis inhibition involving ERK1/2 …
  1027. Personality, psychopathology, and obesity in females: a descriptive study.
  1028. Pharmacokinetics of Fenfluramine and Neuroleptics in the Treatment of Refractory Schizophrenia
  1029. Pharmacologic Approaches to Psychotropic-Induced Weight Gain
  1030. Pharmacologic management for polycystic ovary syndrome: Weight loss
  1031. Pharmacologic therapy of obesity
  1032. Pharmacologic treatment of obesity
  1033. Pharmacologic treatment of obesity: pitfalls and new promises
  1034. Pharmacological action of a pregnane glycoside, russelioside B, in dietary obese rats: impact on weight gain and energy expenditure
  1035. Pharmacological and therapeutic secrets of plant and brain (endo) cannabinoids
  1036. Pharmacological approaches to appetite suppression
  1037. Pharmacological Effect of Histone Deacetylase Inhibitors on Pulmonary Arterial Hypertension
  1038. Pharmacological Management of Obesity: A Century of Expert Opinions in Cecil Textbook of Medicine
  1039. Pharmacological Management of the Obese Patient
  1040. Pharmacological Review of Caralluma R.Br. with Special Reference to Appetite Suppression and Anti-Obesity
  1041. Pharmacological studies of Cordia salicifolia Cham in normal and diabetic rats
  1042. Pharmacological treatment for obesity in adults: an umbrella review
  1043. Pharmacological treatment of obesity
  1044. Pharmacological treatment of obesity
  1045. Pharmacological treatment of obesity in clinical practice
  1046. Pharmacological treatment of obesity: the past, the present and the future
  1047. Pharmacological Treatments and Natural Biocompounds in Weight Management
  1048. Pharmacologically induced weight loss is associated with distinct gut microbiome changes in obese rats
  1049. Pharmacology of appetite suppression: implication for the treatment of obesity
  1050. Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome
  1051. Pharmacotherapy & Surgical Interventions Available for Obesity Management and Importance of Pancreatic Lipase Inhibitory Phytomolecules as Safer Anti …
  1052. Pharmacotherapy & Surgical Interventions Available for obesity management and importance of pancreatic lipase inhibitory Phytomolecules as safer anti-obesity …
  1053. Pharmacotherapy for obesity
  1054. Pharmacotherapy for obesity—trends using a population level national database
  1055. Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials
  1056. Pharmacotherapy for obesity: novel agents and paradigms
  1057. Pharmacotherapy for weight loss in cirrhosis and liver transplantation: translating the data and underused potential
  1058. Pharmacotherapy Management of Obesity
  1059. Pharmacotherapy of obesity: currently marketed and upcoming agents
  1060. Pharmacotherapy of type 2 diabetes: An update and future directions
  1061. Phenelzine-based probes reveal Secernin-3 is involved in thermal nociception
  1062. Phenolic-rich jaboticaba (Plinia jaboticaba (Vell.) Berg) extracts prevent high-fat-sucrose diet-induced obesity in C57BL/6 mice
  1063. Phenotype of neurons in the nucleus of the solitary tract that express CCK-induced activation of the ERK signaling pathway
  1064. Physiological process of fat loss
  1065. Phytochemical Profile, α-Glucosidase, and α-Amylase Inhibition Potential and Toxicity Evaluation of Extracts from Citrus aurantium (L) Peel, a Valuable By-Product …
  1066. PHYTOCHEMICALS AND REGULATION OF THE ADIPOCYTE LIFE
  1067. Phytochemicals and regulation of the adipocyte life cycle
  1068. Phytochemicals in regulating fatty acid β-oxidation: Potential underlying mechanisms and their involvement in obesity and weight loss
  1069. Phytochemicals in the control of human appetite and body weight
  1070. Phytochemistry profile of rosella and jambolan extracts and the therapeutic effects on obesity
  1071. Phytochemistry, bioactivity: suggestion of Ceratonia siliqua L. as neurodegenerative disease therapy
  1072. Phytocompounds as potential agents to treat obesity-cardiovascular ailments
  1073. Pinostrobin: An Adipogenic Suppressor from Fingerroot (Boesenbergia rotunda) and Its Possible Mechanisms
  1074. Pinus koraiensis seed oil (PinnoThinTM) supplementation reduces body weight gain and lipid concentration in liver and plasma of mice
  1075. Pituitary adenylate cyclase activating polypeptide inhibits A10 dopamine neurons and suppresses the binge-like consumption of palatable food
  1076. Plant extracts with appetite suppressing properties for body weight control: a systematic review of double blind randomized controlled clinical trials
  1077. Plant species used in the treatment of diabetes by South African traditional healers: An inventory
  1078. Plants used against obesity in Turkish folk medicine: A review
  1079. Plants with potential use on obesity and its complications
  1080. Plants’ metabolites as potential antiobesity agents
  1081. Polymorphisms in the endocannabinoid receptor 1 in relation to fat mass distribution
  1082. Polyphenols and Obesity
  1083. Pomegranate vinegar beverage reduces visceral fat accumulation in association with AMPK activation in overweight women: A double-blind, randomized, and …
  1084. Population-based placental weight ratio distributions and determinants of placental weight ratios
  1085. Position of the Academy of Nutrition and Dietetics: Interventions for the Treatment of Overweight and Obesity in Adults
  1086. Possible anti-obesity therapeutics from nature–A review
  1087. Possible Signaling Pathways in the Gut Microbiota–Brain Axis for the Development of Parkinson’s Disease Caused by Chronic Consumption of Food Additives
  1088. Post-Translational Regulation of Glucokinase in Hypothalamic Neurons
  1089. Potential assessment of CYP450s and UGTs inhibition by salicylic acid in rat and human supersomes’ in vitro’
  1090. Potential bacterial biofilm, MRSA, and DHFR inhibitors based on new morpholine-linked chromene-thiazole hybrids: One-pot synthesis and in silico study
  1091. Potential effects of sulforaphane to fight obesity
  1092. Potential functions of gonadotropin inhibitory hormone and dynorphin in broiler breeder reproduction
  1093. Potential mechanisms of atypical antipsychotic-induced metabolic derangement: clues for understanding obesity and novel drug design
  1094. POTENTIAL OF PHENYLPROPANOLAMINE AND MONENSIN FOR BODY WEIGHT CONTROL AND AD LIBITUM FEEDING OF BROILER BREEDERS FROM …
  1095. Potential of traditional medicinal plants for treating obesity: a review
  1096. Potential role of neuropeptide ligands in the treatment of overeating
  1097. Practical Aspects of Obesity Treatments: Combination Therapies
  1098. Pre-meal tomato (Lycopersicon esculentum) intake can have anti-obesity effects in young women?
  1099. Pre-operative evaluation for Cardiac Autonomic Neuropathy and their behavior during Regional Anaesthesia
  1100. Prebiotic attenuation of olanzapine-induced weight gain in rats: analysis of central and peripheral biomarkers and gut microbiota
  1101. Precision medicine in obesity and type 2 diabetes: the relevance of early-life exposures
  1102. Precision obesity treatments including pharmacogenetic and nutrigenetic approaches
  1103. Predictors of weight change following smoking cessation
  1104. Preformulation characterization and in vivo absorption in beagle dogs of JFD, a novel anti-obesity drug for oral delivery
  1105. Prescription appetite suppressants: A drug utilization study using a claims database
  1106. Prevalence of overweight and obesity and body image perception amongst black South African female nurses practicing in Durban, KwaZulu-Natal, South …
  1107. Preventing inter-generational metabolic consequences of maternal obesity with exercise
  1108. Prevention and control effects of edible fungi and their active ingredients on obesity: An updated review of research and mechanism
  1109. Prevention and treatment of obesity-related cardiovascular diseases by diet and medicinal plants
  1110. Prevention of diet-induced obesity in rats by oral application of collagen fragments
  1111. Preventive effect of Caralluma fimbriata against high-fat diet induced injury to heart by modulation of tissue lipids, oxidative stress and histological changes in Wistar …
  1112. Preventive effect of Caralluma fimbriata vs. Metformin against high-fat diet-induced alterations in lipid metabolism in Wistar rats
  1113. Primary health care management of overweight and obese adults in Riyadh City, Saudi Arabia: current status and potential quality improvement through the fit and …
  1114. Privileged scaffolds as MAO inhibitors: Retrospect and prospects
  1115. Projection neurons in the cortex and hippocampus: differential effects of chronic khat and ethanol exposure in adult male rats
  1116. Promotion of hepatic lipid oxidation and gluconeogenesis as a strategy for appetite control
  1117. Propionate inhibits fat deposition via affecting feed intake and modulating gut microbiota in broilers
  1118. Protective effect of Caralluma fimbriata against high-fat diet induced testicular oxidative stress in rats
  1119. Protective Effect of Pinus koraiensis Needle Water Extract Against Oxidative Stress in HepG2 Cells and Obese Mice
  1120. Protective effect of rosmarinic acid-rich extract from Trichodesma khasianum Clarke against microbiota dysbiosis in high-fat diet-fed obese mice
  1121. Protective effect of Spirulina against bone fragility induced by Garcinia cambogia in high-fat diet induced obese rats
  1122. Protective effects of Cyathula prostrata leaf extract on olanzapine-induced obese rats
  1123. Protective Effects of Medicinal Plant-Based Foods against Diabetes: A Review on Pharmacology, Phytochemistry and Molecular Mechanisms
  1124. Proton NMR for detection, identification and quantification of adulterants in 160 herbal food supplements marketed for weight loss
  1125. Psychological Factors Influencing Weight Loss and Weight Regain Following Bariatric Surgery
  1126. Psychopharmacological neuroprotection in neurodegenerative disease: heuristic clinical applications
  1127. Psychotropic medication-induced weight gain or loss looked through the lens of age and psychiatric diagnoses: A narrative review
  1128. Psychotropic Medications Weight Gain: A Clinical Dilemma Looked Through the Lens of Therapeutic Challenges, Complementary Approaches and …
  1129. Purification and structure analysis of mammosphere-forming inhibitors derived from Cynanchum auriculatum
  1130. Qualitative and quantitative determination of the effective components of the plants in different herbal slimming products in Turkey by HPLC
  1131. Quality control of dietary supplements: An economic green spectrofluorimetric assay of Raspberry ketone and its application to weight variation testing
  1132. Quetiapine and novel PDE10A inhibitors potentiate the anti-BuChE activity of donepezil
  1133. Regional differences in the mechanisms underlying the modulation of noradrenaline efflux in the brain by the CNS stimulant, d-amphetamine: A dual-probe …
  1134. Regulated effects of Capsicum frutescens supplemented diet (CFSD) on fasting blood glucose level, biochemical parameters and body weight in alloxan …
  1135. Relationship Between Urban Green Spaces and Birthweight
  1136. Repurposing available drugs for neurodevelopmental disorders: the fragile X experience
  1137. Research progress of analysis of illegal additives in weight-reducing dietary supplements.
  1138. Rethinking thin: The new science of weight loss–and the myths and realities of dieting
  1139. Reversal of a feeding-reward system by dexfenfluramine: neurochemical involvement
  1140. Review Paper Monoamine oxidase inhibitors: A review concerning dietary tyramine and drug interactions
  1141. Reward-induced eating: therapeutic approaches to addressing food cravings
  1142. Risks associated with herbal slimming remedies
  1143. Risks associated with the use of Garcinia as a nutritional complement to lose weight
  1144. Risks Associated with the Use of Garcinia as a Nutritional Complement to Lose Weight
  1145. Risks Associated with the Use of Garcinia as a Nutritional Complement to Lose Weight. Nutrients 2021, 13, 450
  1146. Role of neurotrophic factors in adaptations to drugs of abuse in the mesolimbic dopamine system
  1147. Roles of Corticotropin‐Releasing Factor, Neuropeptide Y and Corticosterone in the Regulation of Food Intake In Xenopus laevis
  1148. Satiety induced by neuropeptide FF and gastrin in birds
  1149. Screening and determination of sibutramine in adulterated herbal slimming supplements by HPTLC-UV densitometry
  1150. Sensory perception drives food avoidance through excitatory basal forebrain circuits
  1151. Serotonergic responsiveness in hypothalamic neurons
  1152. Serotonin reuptake inhibitors and cardiovascular diseases: a platelet connection
  1153. Shell Shock Doctors: Neuropsychiatry in the Trenches, 1914-18
  1154. Sibutramine (Hidden Ingredient)-Induced Psychosis, Associated with the Use of Herbal Slimming Product, A Case Report
  1155. Sibutramine detection in weight-loss products using a sodium/phosphorus dual-doped carbon nanotubes modified electrode
  1156. Simmondsin for weight loss in rats
  1157. Simple and sensitive determination of sibutramine in slimming tea beverages using a carbon screen‐printed electrode with adsorptive stripping voltammetry
  1158. Simply Keto: A Practical Approach to Health & Weight Loss with 100+ Easy Low-Carb Recipes
  1159. Simultaneous analysis of four diuretic drugs by HPLC and its application to health food supplements advertising weight reduction
  1160. Simultaneous determination of eight adulterants in weight management supplements and herbs by HPLC–DAD and LC–MS/MS
  1161. Simultaneous determination of pharmaceutical components in dietary supplements for weight loss by capillary electrophoresis tandem mass spectrometry
  1162. Simultaneous determination of seven adulterants in slimming functional foods by HPLC–ESI–MS/MS
  1163. Slimming Meals That Heal: An Empath’s Guide to Evading Relationships That Drain You and Restoring Your Health and Power
  1164. Slimming Meals that Heal: Lose Weight Without Dieting, Using Anti-inflammatory Superfoods
  1165. Smart Food: Diet and Nutrition for Maximum Brain Power
  1166. Smoking cessation, weight gain, and DRD4 −521 genotype
  1167. Striatal reward activity and antipsychotic-associated weight change in patients with schizophrenia undergoing initial treatment
  1168. Structural determinants of oleoyl-estrone slimming effects
  1169. Structure determination of neurotensin receptor 1 variants functionally expressed in e. coli
  1170. Structure-guided Design and Optimization of small Molecules as Pancreatic Lipase Inhibitors using Pharmacophore, 3D-QSAR, Molecular Docking, and Molecular …
  1171. Structure–Activity relationship of halophenols as a new class of protein tyrosine kinase inhibitors
  1172. Studies of synthetic particles and nerve endings on mass transport and kinetics and inhibition of the deglycosylated dopamine transporter
  1173. Studies on the 3, 4-methylenedioxymethamphetamine (MDMA)-induced dysregulation of energy metabolism and its neurochemical consequences
  1174. Studies on the Leaves of Punica Granatum Linn. and its Invitro Inhibition of Ache for Potential Use in Alzheimer’s Treatment
  1175. Studies on the mechanism of drug-induced lipidosis: Cationic amphiphilic drug inhibition of lysosomal phospholipases A and C
  1176. Substance Use Disorder: Biological Mechanisms, Clinical Effects and Neuroadaptations
  1177. Supply of over-the-counter weight-loss products from community pharmacies
  1178. Surgery & Medicine for Weight Loss
  1179. Sympathetic mechanisms in diet‐induced thermogenesis: modification by ciclazindol and anorectic drugs
  1180. Synthesis and In Vitro Protein Tyrosine Kinase Inhibitory Activity of Furan-2-yl(phenyl)methanone Derivatives
  1181. Synthesis and neuromodulatory effects of TRH-related peptides: inhibitory activity on catecholamine release in vitro
  1182. Synthesis and structure-activity studies on inhibitors of Tripeptidyl peptidase II
  1183. Targeted Molecular Strategies for Genetic Neurodevelopmental Disorders: Emerging Lessons from Dravet Syndrome
  1184. TDIQ (5, 6, 7, 8-tetrahydro-1, 3-dioxolo [4, 5-g] isoquinoline) inhibits the consumption of “snacks” in mice
  1185. The 10-Day Belly Slimdown: Lose Your Belly, Heal Your Gut, Enjoy a Lighter, Younger You
  1186. The Abundance Diet: The 28-day Plan to Reinvent Your Health, Lose Weight, and Discover the Power of Plant-Based Foods
  1187. THE ABUSE OF WEIGHT-LOSS METHODS IN ATHLETICS
  1188. The amphetamine debate: the use of adderall, ritalin and related drugs for behavior modification, neuroenhancement and anti-aging purposes
  1189. The Body Code: A Personal Wellness And Weight Loss Plan At The World Famous Green Valley Spa
  1190. The brain: what everyone needs to know®
  1191. The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia
  1192. The cerebrovascular and neurological impact of chronic smoking on post-traumatic brain injury outcome and recovery: an in vivo study
  1193. The Combined Neuropharmacology and Toxicology of Major’Bath Salts’ Constituents MDPV, Mephedrone, and Methylone
  1194. The Diet Pill Guide: The Consumer’s Book of Over-the-counter and Prescription Weight-loss Pills and Supplements
  1195. The disposition of cannabinergic ligands in an in vitro model of the blood-brain barrier
  1196. The Dukan diet: 2 steps to lose the weight, 2 steps to keep it off forever
  1197. The effect of acute MDMA administration on body temperature, serum corticosterone and neurotransmitter concentrations in male and female rats
  1198. The effect of caffeine, green tea and tyrosine on thermogenesis and energy intake
  1199. The effect of LPS and ketoprofen on cytokines, brain monoamines, and social behavior in group-housed pigs
  1200. The effectiveness and safety of pharmaceuticals to manage excess weight post-bariatric surgery: a systematic literature review
  1201. The effectiveness of popular, non‐prescription weight loss supplements
  1202. The Effects Of A Structured Lifestyle Intervention Program In Conjunction With Dietary Supplementation On Weight Loss And Risk F
  1203. The effects of an alpha-glucoside hydrolase inhibitor on glycemia and the absorption of sucrose in man determined using a tracer method
  1204. THE EFFECTS OF CHRONIC AMPHETAMINE ADMINISTRATION UPON MOUSE BRAIN CATECHOLAMINE CONTENT AND SYNTHESIS.
  1205. The effects of housing, dietary changes and chronic restraint stress on body weight and metabolic parameters in the male wistar rat
  1206. The efficacy of Phaseolus vulgaris as a weight-loss supplement: a systematic review and meta-analysis of randomised clinical trials
  1207. The efficacy of short-term weight loss programs and consumption of natural probiotic bryndza cheese on gut microbiota composition in women
  1208. The encyclopedia of the brain and brain disorders
  1209. The Experiences of Living with Excess Weight as an Adolescent: Everyday Life and Healthcare Encounters
  1210. The Fast Beach Diet: The Super-Fast Plan to Lose Weight and Get In Shape in Just Six Weeks
  1211. The FastLife: Lose Weight, Stay Healthy, and Live Longer with the Simple Secrets of Intermittent Fasting and High-intensity Training
  1212. The Green Smoothie Bible: Super-nutritious Drinks to Lose Weight, Boost Energy and Feel Great
  1213. The hungry brain: outsmarting the instincts that make us overeat
  1214. The impact of Citrus aurantium fruit juice on Bodyweight and Haematological Parameters of Wistar rats
  1215. The Impact of Over the Counter (OTC) Weight Loss Product Television Advertisements on the Consumption of OTC Weight Loss Products and Other Diet …
  1216. The inhibition of tyramine oxidation and the tyramine hypertensive response (“cheese effect”) may be independent phenomena
  1217. The Isolation and identification of α-glucosidase and lipase inhibitors from samoan plant extracts
  1218. The Juice Lady’s Living Foods Revolution: Eat Your Way to Health, Detoxification, and Weight Loss with Delicious Juices and Raw Foods
  1219. The Juice Lady’s weekend weight-loss diet: Two days to a new dress size
  1220. The Leptin Boost Diet: unleash your fat-controlling hormones for maximum weight loss
  1221. The medial forebrain bundle: evidence for multiple systems of reward.
  1222. The Mediterranean Prescription: meal plans and recipes to help you stay slim and healthy for the rest of your life
  1223. The neurochemical effects of methcathinone
  1224. The novel atypical dopamine transport inhibitor CT-005404 has pro-motivational effects in neurochemical and inflammatory models of effort-based dysfunctions …
  1225. The Novel Atypical Dopamine Uptake Inhibitor (S)-CE-123 Partially Reverses the Effort-Related Effects of the Dopamine Depleting Agent Tetrabenazine and …
  1226. The Perricone Weight-loss Diet: A Simple 3-part Plan to Lose the Fat, the Wrinkles, and the Years
  1227. The potential of monensin for body weight control and ad libitum feeding of broiler breeders from day-old to sexual maturity
  1228. The protein tyrosine phosphatase 1B inhibitor MSI-1436 stimulates regeneration of heart and multiple other tissues
  1229. The regulation of pulmonary vascular tone by neuropeptides and the implications for pulmonary hypertension
  1230. The Relationship Between Body Mass Index, the Use of Prescription Weight-Loss Medication, and Nonprescription Supplements for Weight Loss
  1231. The Relationship Between Free Sugar Intake and Long-Term Weight Change in a cohort of Swedish Older Adults
  1232. The relationship between smoking cessation, depression and weight gain: a mixed method study
  1233. The relative efficacy of Advanced Brain Food and a homeopathic complex (Quietude) in the management of Attention Deficit Hyperactivity Disorder (ADHD) in males …
  1234. The role of leptin as a neuroimmune mediator of inflammation
  1235. The Role of Leptin-Melanocortin System Gene Variants in Antipsychotic-Induced Weight Gain
  1236. The role of neuronal mTORC1 signaling in the regulation of physiological processes
  1237. The Swift Diet: 4 Weeks to Mend the Belly, Lose the Weight, and Get Rid of the Bloat
  1238. The therapeutic properties of Juniperus communis L.: Antioxidant capacity, bacterial growth inhibition, anticancer activity and toxicity
  1239. The thermogenic properties of ephedrine/methylxanthine mixtures: animal studies
  1240. The Treatment of Brain Inflammation in Alzheimer’s Disease. Can Traditional Medicines Help
  1241. The Use of Carnitine and Pyruvate in Weight Management
  1242. The use of green coffee extract as a weight loss supplement: a systematic review and meta-analysis of randomised clinical trials
  1243. The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: a multi-center study
  1244. The Weigh Down Diet: Inspirational Way to Lose Weight, Stay Slim, and Find a New You
  1245. The Weight of Temptation
  1246. The Whitaker wellness weight loss program
  1247. The β-adrenergic antagonist propranolol partly abolishes thermogenic response to bioactive food ingredients
  1248. Therapy for neurobehavioral disorders in epilepsy
  1249. Thermogenic effect of beta-sympathicomimetic compounds extracted from Citrus aurantium in humans
  1250. TIGHTENING THE BELT ON THE WEIGHT-LOSS INDUSTRY
  1251. Timing of caloric intake during weight loss differentially affects striatal dopamine transporter and thalamic serotonin transporter binding
  1252. Total Thyroidectomy and Subsequent Weight Gain in Pediatric Populations
  1253. Toxicity and feeding inhibition of neem leaf extract (Azadirachta indica) against Plutella xylostella larvae on cabbage.
  1254. Transcript of protein kinase A knock-down modulates feeding behavior and neuropeptide Y gene expression in phenylpropanolamine-treated rats
  1255. Transgenic mice overexpressing neuropeptide Y: An experimental model of metabolic and cardiovascular diseases
  1256. Traumatic Brain Injury: Assessing the Pathogenic Impact of Chronic Smoking and Potential Countermeasures
  1257. Treatment of clozapine-associated weight gain: a systematic review
  1258. Triple reuptake inhibitors: a patent review (2006–2012)
  1259. Ultrabright red-emitted aggregation-induced luminescence microspheres-based lateral flow immunoassay for furosemide detection in slimming products
  1260. Update on management of the oral and maxillofacial surgery patient on selective serotonin reuptake inhibitors
  1261. Using herbal remedies to maintain optimal weight
  1262. Validation of the method for determination of Phenolphthalein and Sibutramine in weight‐loss functional foods from Viet Nam by UPLC‐MS/MS
  1263. Very-low-calorie ketogenic diet with aminoacid supplement versus very low restricted-calorie diet for preserving muscle mass during weight loss: a pilot double …
  1264. Viagra exposure effects on learning and memory, some neurotransmitters and oxidative indices in male mice
  1265. Weighing in: Nutrition and Weight Management
  1266. Weight concerns, body image, and smoking continuation in pregnant women in rural Appalachia
  1267. Weight gain in smokers after quitting cigarettes: meta-analysis
  1268. Weight is controlled by eating patterns, not by foods or drugs: Reply to comments on “Satiety. No way to slim”
  1269. Weight Loss
  1270. Weight loss associated with sodium‐glucose cotransporter‐2 inhibition: a review of evidence and underlying mechanisms
  1271. Weight loss by Ppc-1, a novel small molecule mitochondrial uncoupler derived from slime mold
  1272. Weight Loss Medication: A Preliminary Study to Assess If it Works
  1273. Weight loss supplements in the Lebanese market: safety, efficacy and use
  1274. Weight Loss that Works
  1275. WEIGHT MANAGEMENT IN THE POST-EPHEDRA ERA
  1276. Weight-loss Drugs
  1277. Weight-loss strategies of South African female university students and comparison of weight management-related characteristics between dieters and non …
  1278. Weight-loss supplements: what is the evidence
  1279. Weighty issues: Semiotic notes on dieting as a secular ritual
  1280. What Your Doctor Won’t Tell You about Weight Loss: Mesotherapy and More
  1281. Why You Can’t Lose Weight: Why It’s So Hard to Shed Pounds and What You Can Do about It
  1282. Wild Mediterranean dietary plants as inhibitors of pancreatic lipase
  1283. Workplace wellness programs targeting weight outcomes in men: A scoping review
  1284. Y2 Receptor Agonism and AgRp Neurons in the Co-Ordinated Control of Energy Balance’.
  1285. Your brain on food: How chemicals control your thoughts and feelings
  1286. YOUR LOSS IS MY GAIN: MARKETING WEIGHT LOSS
  1287. Zinc elevates neuropeptide Y levels in rat pheochromocytoma cells by a mechanism independent of L-channel mediated inhibition of release
Related Posts

Conditioned Place Preference

Mediterranean Diet

Calorie Restriction & Lifespan Extension

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

4
    4
    Your Cart
    HYPNOTIC
    Size:

    100g

    1 X $275.00 = $275.00
    VICTORIOUS
    Size:

    100g

    1 X $275.00 = $275.00
    ACB
    Size:

    100g

    1 X $275.00 = $275.00
    PURGE 2.0 - CAPSULES
    Size:

    100g

    1 X $275.00 = $275.00
    Subtotal $1,100.00
    Shipping, taxes, and discounts calculated at checkout.
    View CartContinue ShoppingCheckout$1,100.00